Image Analysis: A New Tool in the Study of Mammalian Vascular Smooth Muscle Function by Wight, Marti
 
 
 
 
 
 
 
https://theses.gla.ac.uk/ 
 
 
 
 
Theses Digitisation: 
https://www.gla.ac.uk/myglasgow/research/enlighten/theses/digitisation/ 
This is a digitised version of the original print thesis. 
 
 
 
 
 
 
 
 
Copyright and moral rights for this work are retained by the author 
 
A copy can be downloaded for personal non-commercial research or study, 
without prior permission or charge 
 
This work cannot be reproduced or quoted extensively from without first 
obtaining permission in writing from the author 
 
The content must not be changed in any way or sold commercially in any 
format or medium without the formal permission of the author 
 
When referring to this work, full bibliographic details including the author, 
title, awarding institution and date of the thesis must be given 
 
 
 
 
 
 
 
 
 
 
 
 
 
Enlighten: Theses 
https://theses.gla.ac.uk/ 
research-enlighten@glasgow.ac.uk 
Image analysis: A new tool in the study of 
mammalian vascular smooth muscle function.
A thesis presented for the degree of Master of Science
by
Martin Wight
March 1990 Institute of Physiology,
University of Glasgow, 
Glasgow, 
Scotland.
ProQuest Number: 11007348
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com p le te  manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uest
ProQuest 11007348
Published by ProQuest LLC(2018). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C ode
Microform Edition © ProQuest LLC.
ProQuest LLC.
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106- 1346
CONTENTS
List o f Contents
Page No.
CONTENTS 1
LIST OF FIGURES 4
LIST OF TABLES 8
ACKNOWLEDGEMENTS 9
DECLARATION & PUBLICATIONS 10
SUMMARY 11
GENERAL INTRODUCTION 14
GENERAL METHODS 20
CHAPTER 1 _  28-55
Receptor populations of the rabbit small saphenous vein 
and saphenous artery.
INTRODUCTION 29
MATERIALS & METHODS 33
RESULTS 36
DISCUSSION 50
CHAPTER 2 56-88
Role of the endothelium in the rabbit small saphenous 
vein and saphenous artery.
INTRODUCTION 57
2
MATERIAL & METHODS 62
RESULTS 63
DISCUSSION 82
CHAPTER 3
Rhythmic activity in the rat thoracic aorta & portal vein 
and the rabbit saphenous arteiy.
89-103
INTRODUCTION 90
MATERIAL & METHODS 93
RESULTS 94
DISCUSSION 101
CHAPTER 4
Electrical field stimulation of the rabbit small saphenous 
vein.
104-124
INTRODUCTION 105
MATERIAL & METHODS 108
RESULTS 110
DISCUSSION 122
GENERAL DISCUSSION 125
REFERENCES 130
APPENDIX 143
3
List of Figures
Figure No. Description Page No.
1 Side view of the organ-bath. 22
2 Diagrammatic representation of a blood vessel. 23
3 Flow diagram showing options with image analysis. 27
Percentage length and width changes caused by the 37
noradrenaline (ai/(X2-agonist) isolated rabbit small 
saphenous vein .
Cumulative concentration response curve for the intra- 39
luminal application of noradrenaline in the rabbit 
saphenous artery.
Cumulative concentration response curve for the intra- 41
luminal application of noradrenaline in the rabbit small 
saphenous vein.
Comparison between the cumulative concentration 42
response curves for intraluminally-applied noradrenaline 
obtained with image analysis and the cut-ring method in 
the rabbit small saphenous vein.
Effects of the ai-antagonist prazosin without and then 44
with the a 2 -antagonist rauwolscine on responses to 
noradrenaline in the rabbit small saphenous vein.
4
Effects of the antagonists prazosin and/or rauwolscine on 
the constriction produced by three agonists, noradrenaline,
UK-14304 (0C2 ) and BHT-920 (0C2) in the rabbit small 
saphenous vein.
Effects of the antagonists prazosin and/or rauwolscine on 
the constriction produced by the agonist noradrenaline in 
the rabbit saphenous artery.
Effect of angiotensin on the constriction produced by 
noradrenaline alone, and then in combination with 
rauwolscine and then with rauwolscine + prazosin.
Effect of acetylcholine on the constriction produced by 
noradrenaline in the rabbit small saphenous vein.
Effect of acetylcholine on the constriction produced by 
noradrenaline in the rabbit small saphenous vein, in the 
presence of flurbiprofen.
Effect of sodium nitroprusside, without and then with 
acetylcholine, on the constriction produced by noradrenaline 
in the rabbit small saphenous vein.
Effect of acetylcholine, without and then with sodium 
nitroprusside, on the constriction produced by noradrenaline 
in the rabbit small saphenous vein.
Effect of sodium nitroprusside, without and then with 
acetylcholine, on the constriction produced by noradrenaline 
in the rabbit saphenous artery.
Effect of acetylcholine, without and then with sodium 
nitroprusside, on the constriction produced by noradrenaline 
in the rabbit saphenous artery.
18 Effect of sodium nitroprusside, without and then with 
acetylcholine, on the constriction produced by noradrenaline 
in the rabbit saphenous artery (13 mmHg).
19 Effect of acetylcholine, without and then with sodium 
nitroprusside, on the constriction produced by noradrenaline 
in the rabbit saphenous artery (13 mmHg).
20 Effect of acetylcholine on the constriction produced by 
noradrenaline in the rabbit saphenous artery.
21 Effect of acetylcholine on the constriction produced by 
noradrenaline in the rabbit saphenous artery, in the presence 
of haemoglobin throughout.
22 Effect of acetylcholine on the constriction produced by 
noradrenaline in the rabbit small saphenous vein.
23 Effect of acetylcholine on the constriction produced by 
noradrenaline in the rabbit saphenous artery, in the presence 
of haemoglobin throughout.
24 Effect of acetylcholine on the constriction produced by 
noradrenaline in the rabbit small saphenous vein.
25 Effect of acetylcholine on the constriction produced by 
noradrenaline in the rabbit saphenous artery, in the presence 
of intra- and extraluminally applied haemoglobin throughout.
26 Rhythmic activity in the rat portal vein constricted with 
noradrenaline.
27 Rhythmic activity caused by noradrenaline in the rabbit 
saphenous artery set up under a venous pressure of 13 mmHg.
28 Rhythmic activity caused by noradrenaline in the rabbit 
saphenous artery set up under a venous pressure of 13 mmHg.
73
74
75
76
78
79
80
81
95
97
98
6
29 Absence of rhythmic activity in the rabbit saphenous artery 100
set up under an arterial pressure of 100 mmHg and constricted
with noradrenaline.
30 Constriction produced by electrical field stimulation of the 111
rabbit small saphenous vein.
31 Constriction produced by electrical field stimulation of the 113
rabbit small saphenous vein in the presence of rauwolscine.
32 Constriction produced by electrical field stimulation of the 114
rabbit small saphenous vein in the presence of rauwolscine
and prazosin.
33 Constriction produced by electrical field stimulation of the 115
rabbit small saphenous vein.
34 Constriction produced by electrical field stimulation of the 116
rabbit small saphenous vein in the presence of prazosin.
35 Constriction produced by electrical field stimulation of the 117
rabbit small saphenous vein under a pressure of 15 C111H2O.
36 Constriction produced by electrical field stimulation of the 118
rabbit small saphenous vein under a pressure of 10 cmH2 0 .
37 Constriction produced by electrical field stimulation of the 119
rabbit small saphenous vein under a pressure of 5 cmH20.
38 Relationship between the transmural pressure and the 121
percentage change in width in the rabbit small saphenous
vein.
7
List of Tables
Table No. 
1
2
Description
Longitudinal tension and transmural pressure values 
for each of the preparations studied using image 
analysis.
Protocol for examination of agonist + antagonists 
potencies in the rabbit small saphenous vein and 
saphenous artery.
Page No. 
21
34
8
ACKNOWLEDGEMENTS
I would firstly like to thank Dr. V.A. Moss for his constant help and encouragement 
throughout this project and letting me clutter up his otherwise very tidy (?) lab. I would 
like to thank Prof. J.C. McGrath for his invaluable advice on the pharmacological 
aspects of my project and also Prof. S.M. Jennett and the Institute of Physiology for 
allowing me to work in the department.
Thanks to Alison (for her advice), Craig (for doing literature searches for me, 
sometimes unnecessarily), Billy (for talking about the football only when Rangers got 
beat) and Joyce (for her filing system).
A special thanks also to my family for their support and for putting up with me.
9
DECLARATION
The experimental work and other research which is contained within this thesis was 
undertaken wholly by myself. Some of the results have been published during the 
period of this study, details of which are given below.
PUBLICATION
McGrath, J.C., Moss, V.A. & Wight, M. (1990) Responses mediated by 
postjunctional a-adrenoceptors of the isolated rabbit lateral saphenous vein measured 
by on-line video image analysis. J. Physiol. 422 52P.
10
SUMMARY
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SUMMARY
The aim of this project was to develop a method to measure accurately 
dimensional changes in isolated blood vessel preparations using the technique of 
computerised on-line image analysis. A programme developed to study gut peristalsis 
was modified and refined for use by the image analyser (Magiscan) to study what 
effects various mechanical or chemical stimuli had on the dimensions of the vessels 
examined. Branch-free segments from both the arterial and venous sides of the 
circulation were set up under isotonic conditions with each vessel being subjected to a 
constant transmural pressure and longitudinal tension. The investigations involved 
looking at four different areas of vascular function: these were (1) postjunctional 
receptor populations in the rabbit small saphenous vein and saphenous artery, (2) the 
influence of the endothelium on contractile responses of the rabbit small saphenous vein 
and saphenous artery, (3) rhythmic activity in the rat thoracic aorta, rat portal vein and 
rabbit saphenous artery and finally (4) electrical field stimulation of the rabbit small 
saphenous vein.
(1.1) Agonist and antagonist potency profiles indicate that the rabbit small saphenous 
vein has a heterogeneous postjunctional population of a i-  and oc2 -adrenoceptors, the 
a 2 -adrenoceptors being the more dominant of the two in mediating constriction.
(1.2) Agonist and antagonist potency profiles indicate that the rabbit saphenous artery 
also has a heterogeneous postjunctional population of a i-  and (X2-adrenoceptors. In 
this vessel though the ai-adrenoceptor is the dominant receptor mediating constriction.
(1.3) The particularly high sensitivity to noradrenaline seen in both preparations may 
be due to the recruitment of a population of a 2-adrenoceptors which is not revealed by 
other in vitro techniques.
(2.1) Acetylcholine was able to relax noradrenaline-induced constrictions in both the 
rabbit small saphenous vein and saphenous artery. This relaxation, which was more 
pronounced in the vein, was presumably mediated via the release of EDRF from the 
endothelium.
(2.2) Sodium nitroprusside, an endothelium-independent relaxant, was more effective 
than acetylcholine as a relaxing agent in both the artery and the vein.
(2.3) Addition of haemoglobin, which blocks the action of EDRF, abolished or 
reduced the relaxation to acetylcholine in the artery and vein respectively. This 
provides further evidence for the existence of EDRF involvement in vascular function.
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(3.1) Rhythmic activity was seen in the rat portal vein and the rabbit saphenous 
artery, though in the artery only when the transmural pressure was reduced to venous 
levels.
(3.2) No conclusive evidence was found for the presence of a propagated wave in 
either preparation.
(4.1) Electrical field stimulation of the rabbit small saphenous vein caused a 
vasoconstriction which was evoked by neurally-released noradrenaline.
(4.2) This constriction was shown to be more susceptible to rauwolscine than to 
prazosin, suggesting that the response was primarily via a 2 -adrenoceptors.
(4.3) A small part of the response was resistant to addition of both antagonists, 
suggesting that either the antagonist concentrations were not high enough or that some 
other type of receptor was involved in the response.
This study was not meant to be a comprehensive look at one particular aspect of 
vascular function. Instead a number of areas were examined to show where image 
analysis gave advantages over other in vitro techniques. Results have demonstrated 
image analysis to be a very sensitive and highly reproducible method for the isolated 
study of blood vessel function. In particular the technique mimics more closely the 
results found from in vivo studies. One example of this was the ease with which CX2- 
adrenoceptors could be found both in vivo and when using image analysis but not 
when using other in vitro techniques.
13
GENERAL INTRODUCTION
GENERAL INTRODUCTION
Image analysis
The seeds of image analysis were sown by Alvarez and Zimmerman (1927) who 
developed a method for analysing isolated preparations quantitatively by taking 
photographs on cine film. Their preparation was a section of gut which they marked at 
regular intervals to divide the section into separately defined regions to measure 
intestinal motility. Using calipers they measured by hand the changes in position of the 
markers in a series of 320 photographs which they took of each intestinal section. This 
manual measuring technique, where every frame had to be analysed individually by 
hand, proved to be very laborious. Therefore it was inappropriate to accrue large data 
sets due to the length of time it would take to analyse the data.
Another 54 years passed before any real progress was made in this field. The 
breakthrough was engineered by Moss (1981, 1982a, 1982b) who developed a semi­
automated method which involved a computer-linked digitising tablet (planimeter). 
This much faster technique combined the ability of a trained observer to discriminate the 
relevant features of an image with the speed of computerised “number-crunching”. 
However, this method still involved a large degree of subjective decision making, 
therefore instilling the possibility of observer bias.
To overcome this difficulty required the development of fully computerised image 
analysis techniques. This was supplied by the Magiscan (Joyce Loebl), which via a 
television camera, was used as a computerised image processor. Bell et ah (1982), 
working on individual cat intrafusal muscle fibres, developed the appropriate software 
for the Magiscan to capture images which were digitised and analysed numerically. 
These programmes allowed the real-time analysis of data to be distanced from any 
direct human measurement bias. The programmes, subsequently refined by Moss, were 
then used to measure dimensional changes in a variety of tissues including the vas 
deferens (Moss, 1984), cardiac muscle (Moss et ah, 1986), skeletal muscle (Moss, 
1986; Boyd et ah, 1987) and the smooth muscle of the gastrointestinal tract (Brodie et 
ah, 1987). The technique has more recently been used to study the smooth muscle of 
the mammalian vasculature (McGrath et al., 1990a). Image analysis, a new tool in this 
field, will serve as a good comparison to the more traditional in vitro techniques (e.g. 
isometric perfusions, cut-rings and helical strips) and will show in what spheres this 
technique gives advantage.
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Other in vitro techniques used to study isolated blood vessels:
Cut-rines
The cut-ring preparation was developed by Hooker, Calkins & Fleisch (1976) and 
initially involves the extraction of a suitable length of blood vessel from the animal. 
This length of blood vessel is then cleared of connective tissue and cut transversely into 
3-5 mm sections, or rings, which are each suspended between two 0.2 mm thick wire 
supports. The lower support is connected to a glass tissue holder while the upper 
support is connected by cotton thread to a Grass FT03 isometric transducer to record 
the isometric tension. The preparations are then mounted in separate 30 ml organ-baths 
under a previously determined resting tension. After a suitable period of equilibration 
the tension is re-adjusted to a set value which will be maintained constant throughout 
the rest of the experimental day.
Advantages:
(1) can obtain several sections of the same blood vessel from the same animal.
(2) can build up a lot of data rapidly.
(3) can measure changing properties of a vessel along a short section of its length.
(4) can set up parallel control preparations.
Disadvantages:
(1) region being analysed is very close to site of damage by dissection process, 
therefore technique is invasive.
(2) this invasiveness causes the release of various substances (e.g. intracellular 
potassium) which might effect the response of the tissue.
(3) the effect of intraluminally against extraluminally applied drugs cannot be 
measured separately.
(4) insertion of wires intraluminally might cause damage to endothelium.
(5) only transverse changes in the tension can be analysed.
(6) technique cannot differentiate the relative contributions made by the longitudinal 
and circular smooth muscle layers for each change in tension.
(7) the tension given to the vessel while experimentation proceeds is often an 
unphysiological one.
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(8) the recording is essentially an isometric one.
Helical Strips
The helical strip preparation (see Vanhoutte et al., 1973) is one where a length of 
blood vessel is removed and cleared of any excessive connective tissue. Once cleared 
the vessel is cut into a limited number of 20-30 mm spiral strips, depending on how 
long a section of the preparation is available. The strips are mounted vertically in an 
organ-bath with each end being connected to a strain gauge (Grass FT.03) for 
recording of isometric tension. A period of equilibration is then observed before the 
experiment proper begins.
Advantages:
(1) can obtain several sections of the same blood vessel from the same animal.
(2) can build up a lot of data rapidly.
(3) can differentiate responses produced by drugs applied intraluminally against 
extraluminally using paraffin grease to block entry of drugs extraluminally (see Pascual 
& Bevan, 1979).
(4) can set up parallel control preparations.
Disadvantages:
(1) length of vessel being analysed includes large regions of damage caused by 
"  cutting the vessel into strips, therefore technique is invasive.
(2) this invasiveness causes the release of various substances (e.g. intracellular 
potassium) which might affect the response of the tissue.
(3) only one measurement is recorded per strip.
(4) technique cannot differentiate the relative contributions made by the longitudinal 
and circular smooth muscle layers for each change in tension.
(5) the tension given to the vessel while experimentation proceeds is often an 
unphysiological one.
(6) the recording is essentially an isometric one.
Perfusion
The final in vitro method widely used is the perfusion technique (see Hieble & 
Pendleton, 1979) where the number of tissues set up simultaneously can also be greater
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than one. This method like the other two initially involves the removal of a section of 
blood vessel from the animal, and secondly, the clearing of any excessive connective 
tissue from the surrounds of the preparation. Each preparation is then divided up into 
sections, one for each tissue chamber. Side branches are tied off and each of the 
sections are double-cannulated using an inert plastic (e.g. polyethylene tubing) which is 
held in position with thread. The sections are then mounted vertically in the chambers 
where they can be perfused and superfused with the appropriate solution. This 
technique allows the intraluminal inflow perfusion pressure to be measured and 
recorded for each section using a Statham P23AA transducer and Grass polygraph 
respectively.
Advantages:
(1) can obtain several sections of the same blood vessel from the same animal.
(2) can build up a lot of data rapidly.
(3) can differentiate responses produced by drugs applied intraluminally against 
extraluminally.
(4) The technique is not as invasive as other in vitro methods since the region being 
studied is mostly removed from the sites of damage caused by the dissection process.
Disadvantages:
(1) to obtain several decent sized sections from the same blood vessel requires a very 
long vessel.
(2) if a very long section of vessel is used then there is a good chance the properties 
of the vessel will alter along its length.
(3) only a single overall parameter (pressure) is measurable.
(4) technique cannot differentiate the relative contributions made by the longitudinal 
and circular smooth muscle layers for each change in diameter.
(5) the recording is essentially an isometric one.
Advantages already seen with image analysis
The above is a brief summary of the three in vitro techniques used to study isolated 
blood vessels with a list of their advantages and disadvantages. The development of 
image analysis is an attempt to overcome some if not all of these difficulties and at the 
same time retain the advantages which these techniques possess. In my preliminary
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work using image analysis a few of the more obvious advantages which this technique 
possesses have become apparent:
(1) This technique is less invasive than other in vitro methods, with its ability to draw 
its experimental results from a region far removed from any sites of damage caused by 
the dissection process, particularly of the fragile endothelium.
(2) Another advantage over such methods as the cut-ring preparation is the 
opportunity to study both intra- and extraluminally applied drugs, either separately or 
simultaneously.
(3) Vessels can be set up at their physiological pressure, which with rings or strips 
has to be contrived following calculation of wall tension and wall thickness/lumen 
ratios, and usually is not taken into account at all.
(4) Unlike a simple double-cannulated preparation in which a single parameter 
(pressure) is measured, image analysis can simultaneously quantify changes for several 
different regions of the same preparation and for each region can measure the width and 
length changes of the vessel.
(5) Both rapid changes (up to 50 frames/second) and slower changes for periods of 
several hours can be analysed with the results displayed immediately.
(6) The preparation used for image analysis is maintained at a normal physiological 
transmural pressure with essentially an isotonic, rather than the isometric or 
substantially auxotonic recording forced by other methods.
(7) This image analysis method has been shown to be capable of measuring to a high 
degree of sensitivity and reproducibility, dimensional changes of a fraction of one 
percent being well within the measurable range of this technique.
The above is a list of those advantages which early studies using image analysis has 
uncovered. In the general discussion there will be a full review of the success of this 
image analysis method in the study of the mammalian vasculature together with any 
limitations still present.
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MATERIALS & METHODS
Tissue preparation
There were two species used during this project, male Wistar 250 g rats and albino 
New Zealand rabbits weighing between 2.5 and 3.5 Kg. The rats were killed by a 
blow to the head followed by cervical dislocation. This species was used only briefly 
with the vessels removed being the thoracic aorta and the portal vein. Most 
experiments were performed using rabbits which were killed by stunning followed by 
exsanguination. Blood vessels removed from the rabbit were confined to the 
saphenous artery and the small saphenous vein. The section of saphenous artery was 
taken from just above the knee joint, while the section of small saphenous vein was 
taken from between the knee and the ankle of the rabbit. For all these preparations the 
following experimental procedure has been employed in setting them up.
A 1-2 cm length of the blood vessel was removed and placed in a petri-dish 
containing Krebs. This dish was put on ice and the vessel was cleared of any 
extraneous connective tissue using fine scissors under a dissecting microscope. A 
branch free section of the vessel was then cannulated at either end, with each cannula 
being secured in position with white surgical thread. The vessel plus the cannulae were 
then placed horizontally in a 250 ml perspex organ-bath with the in-going cannula being 
connected to an eight-way tap (manifold) and the outgoing cannula being connected to 
an isotonic transducer (see Fig. 1).
A weight of a pre-determined magnitude was placed on the arm of the transducer to 
exert a longitudinal tension on both the arterial and venous preparations. Table 1 
shows the tension values chosen for each preparation along with the corresponding 
standard values allocated for transmural pressure.
Table 1: Longitudinal tension and transmural pressure values for each of the 
preparations studied using image analysis.
Preparation Longitudinal Tension (g) Transmural pressure(cm H2O)
rabbit small saphenous vein 0.67 20
rabbit portal vein 1.00 20
rabbit saphenous artery 1.00 130
rat thoracic aorta 2.00 130
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■Weight (2-10 g)
Out-gonig 
Cannula
Isotonic 
Transducer
Movable Plate
Eight-way
Manifold
Camera
x-Glass 
Window
7
Preparation In-going
CannulaBrass Plate
Krebs 
Bicarbonate 
Solution
Drainage
Tube
Fig. 1 Side view of the organ-bath within which the vessel is horizontally 
positioned. The in-going cannula is connected to the eight-way tap (manifold) to 
perfuse the vessel with the appropriate solution. The out-going cannula is connected to 
the isotonic transducer to exert a suitable longitudinal tension on the vessel.
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The eight-way tap was attached via silicone tubing to seven separate 50 ml 
reservoirs to supply Krebs bicarbonate, or the appropriate drug-containing solution 
made up using Krebs bicarbonate, to the preparation. Since the out-going cannula was 
much longer than the in-going cannula, and the silicone tubing connecting the 
reservoirs to the eight-way tap had a much greater diameter than the cannula, nearly all 
the resistance to flow was in this out-going cannula. Therefore transmural perfusion 
pressure was determined by the height of the reservoirs above the preparation. For the 
venous preparations the height was maintained at 20 cm, which equals 13 mmHg, 
while for the arterial preparations the height was maintained at 130 cm, which equals 
100 mmHg. These heights were kept constant unless otherwise indicated.
The preparation was momentarily dried off with a tissue to allow lines of a dye 
(Janus green) to be placed across the preparation, using the edge of a cover-slip, to act 
as markers for the Magiscan. The space between two lines corresponded to one 
segment, each segment being a separate, independently recordable region on the blood 
vessel (see Fig. 2).
BANDS 
OF DYE
THREAD TO TIE 
CANNULA TO 
PREPARATION
■IN-GOING CANNULA 
(FROM RESERVOIRS)
BLOOD
VESSEL
— segment 1
— segment 2
— segment 3
— segment 4
•OUT GOING CANNULA 
(ATTACHED TO 
TRANSDUCER)
Fig.2 Diagrammatic representation of a blood vessel showing 4 segments created 
by the dye markers. The dimensional changes (length and width) for each segment can 
be measured separately.
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Once the dye was applied then the organ-bath was rapidly filled with Krebs to 
prevent the tissue from drying out. The organ-bath, eight-way tap and some of the 
accompanying silicone tubing used to connect the eight-way tap to the reservoirs were 
then partially submerged in a larger water-bath. Both baths were then bubbled with 
95% O2 , 5% CO2 . This allowed oxygen to diffuse through the submerged silicone
tubing connecting the reservoirs to the eight-way tap, thereby forming an equilibrium 
concentration with the perfusate running through these tubes. A suitable oxygen 
tension was thus delivered to the tissue via the ingoing cannula which delivers this 
perfusate to the vessel. The temperature in the water-bath was kept at a constant 37°C. 
The bottom of the organ-bath was constructed of brass to allow better heat conduction 
between the water-bath and the organ-bath, therefore maintaining the organ-bath at 
approximately the same temperature as the water-bath.
It is also worth mentioning at this stage that flow rates through the preparation were 
also analysed using a drop-counter placed below the out-going cannula. By linking the 
counter up to a BBC computer the flow could be measured continuously. Results 
showed there to be so little variation in flow with respect to vessel diameter changes 
that the figures will not be quoted in the main results sections.
Image Analysis
Image analysis as a technique requires a camera, normally a standard CCD 
television camera, to capture the image to be studied. This is linked to an image 
analyser (Magiscan) which must perform two functions with thisTmage; it must contain 
both a frame store (at least one) to store the digitised image captured from the camera 
and secondly, it must contain a computer with the appropriate software to manipulate 
this black and white image into a form presentable as a series of numerical values.
This software utilises the fact that there are differences in the brightness of the 
image, i.e. parts of the image are darker or lighter than others. By dividing each image 
into 262,144 separate areas called pixels (each frame consists of 512 columns x 512 
rows), the Magiscan can obtain a separate numerical value for each pixel which is 
determined by the brightness at each region. The values range from 0 to 63 with 0 
being black and 63 being white and the values in between corresponding to a series of 
grey tones between black and white. In this way each frame is converted into a series 
of numerical values for analysis.
This analysis involves the Magiscan firstly determining a frame rate at which to run, 
normally one frame per 3 seconds or for fast analysis one frame per second. It then 
places a window around the area of interest, in this case it is the isolated blood vessel
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preparation. The blood vessel has thin transverse lines of a dye placed along its length 
to act as points of reference for the Magiscan and also to divide the vessel into between 
2 and 4 separate, independently-recordable segments or “bands” for analysis. The dark 
dye lines contrast well with the light appearance of the tissue and the lines are 
recognised as reference points because at these lines there are rapid changes in light 
intensity which the Magiscan can detect. The numerical values obtained for light 
intensity down the vertical plane are differentiated by the Magiscan and displayed as a 
vertical histogram with the bands represented as troughs. This is used to calculate the 
length changes with time for each of the segments on the blood vessel.
The background to the preparation is made uniform using white paper and with 
appropriate lighting conditions the edges of the preparation also appear as areas of rapid 
change in light intensity. Therefore calculation and differentiation of the numerical 
values for light intensity across the horizontal plane are represented by horizontal 
histograms (one for each segment) and are used to calculate the external width changes 
with time for each of the segments on the blood vessel.
So what is achieved for each frame captured by the camera are measurements in 
number of pixels for external width, length and volume (calculated from length and 
width) for each of the segments on the blood vessel. However, in all experiments 
conducted it was seen that the length changes in each preparation were much smaller 
and much less predictable than the corresponding width changes. Since in general the 
length changes were very small and showed no discernible pattern it was decided to 
concentrate our analysis on the width changes occurring in each preparation. Changes 
in the diameter of the isolated blood vessel were considered to be of more physiological 
significance than the corresponding length changes. This is because the resistance in 
blood vessels is inversely related to the fourth power of the radius. Therefore even 
small changes in the diameter of a blood vessel play a more significant role in the 
correct functioning of the intact animal’s cardiovascular system than length changes. 
Since volume is merely calculated from the length and width measurements these 
results, like the length results, will not be quoted in detail in the results section.
Protocol
The same basic protocol was employed for all experiments. Each experiment began 
with a 45 minute equilibration period to allow the blood vessel to settle down after the 
disruption of the dissection and setting-up process. This period was followed by the 5 
minute addition of a sub-maximal concentration of whatever a-adrenoceptor agonist 
was to be used that day. There were two reasons for this procedure; firstly, it 
confirmed the tissue to be still functioning and secondly, it made responses to repeated
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additions of equivalent agonist concentrations more consistent with respect to 
magnitude of the response. After this initial dose of the agonist the preparation was left 
for a further 30 minutes before the experiment proper was started.
Since experiments involved the addition of drugs both extraluminally and much 
more commonly intraluminally, the preparation had to be set up free of any side 
branches. This prevented leaks from the perfusate into the medium bathing the 
preparation and vice versa, therefore allowing confidence in the drug concentrations 
present both outside and inside the preparation. For the intraluminal drug additions the 
drugs were made up to the correct concentration by dilution in a volume of 50 ml of 
Krebs. This solution was then placed in one of the reservoirs and by a switch of the 
relevant tap on the manifold the solution could be perfused through the vessel. 
Addition of drugs extraluminally was achieved by injecting the drug via a syringe 
directly into the Krebs which baths the preparation. The volume of Krebs in this 
bathing medium was maintained at a constant 250ml.
To study the changes in width, occurring with time in a preparation, the Magiscan 
requires control values on which to base these changes. This was achieved by starting 
each experiment with a “control period”. A sequence of 20 photographs were taken at 
the start of each experiment and an average value (in number of pixels) was found for 
the width of each segment on a preparation. Any changes in width occurring 
subsequently in the blood vessel could be compared with these control values, the 
changes being expressed as a percentage decrease or increase over the control value. A 
constriction of the vessel being a percentage decrease and a dilation being a percentage 
increase. These values were then plotted on a graph with the x-axis being time in 
seconds and the y-axis being the percentage change in the width with respect to the 
control period. This graph could then be displayed on screen or be transferred onto A3 
or A4 paper using an Hewlett Packard plotter (see Fig. 3).
Solutions and drugs
The composition of the Krebs bicarbonate was (in mM): NaCl 118.4, NaHC0 3  25, 
KC14.7, KH2P 0 4 1.2, MgS04 1.2, CaCl2 2.5, and glucose 11. Na2EDTA (23 
mM) was also included in the Krebs in all experiments to prevent the oxidative 
degradation of noradrenaline and, unless indicated otherwise, propranolol (1 (iM) and 
cocaine hydrochloride (10 |iM) were also included to inhibit (3-adrenoceptors and 
neuronal uptake of noradrenaline, respectively. Propranolol and cocaine are widely 
recognised as agents which help to increase the potency of various constrictor agents, 
having been used extensively in cut-ring experiments.
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Fig. 3 Flow diagram showing options with image analysis.
The following compounds were used: acetylcholine chloride; angiotensin II (acetate 
salt); Bayer K 8644; BHT-920 (6-allyl-2-amino-5,6,7,8-tetrahydro-4H-thiazolo-[4,5- 
djazepin dihydrochloride; cocaine hydrochloride; sodium flubiprofen dihydrate; bovine 
haemoglobin type 1; (-)-noradrenaline bitartrate; phenylephrine hydrochloride; prazosin 
hydrochloride; propranolol hydrochloride; rauwolscine hydrochloride; sodium 
nitroprusside and UK-14304 (5-bromo-6-[2-imidazolin-2-ylamino]-quinoxaline 
bitartrate). For a full description of their abbreviation, supplier and effect on vascular 
function see appendix 1. All but three of these drugs were made up in there various 
dilutions using distilled water. The exceptions were prazosin and rauwolscine, which 
are both fairly insoluble in water. These were made up by firstly dissolving in alcohol 
prior to the addition of the distilled water to make the correct concentration. 
Noradrenaline was the other exception, with all dilutions being made up in 23 p.M 
EDTA to prevent noradrenaline’s oxidative degradation.
Although a large variety of experiments were completed throughout the year the 
work can be classified into four separate areas of study, each with its own unique 
protocol to be expanded on individually in separate chapters. The four aspects of blood 
vessel function which were studied were as follows; (1) the postjunctional receptor 
populations present in the rabbit small saphenous vein and saphenous artery, (2) the 
role of the endothelium in response to addition of various drugs to the rabbit small 
saphenous vein and saphenous artery, (3) the attempt to show rhythmic activity in the 
rat thoracic artery, rat portal vein and rabbit saphenous artery, (4) the response 
produced by electrical field stimulation of the rabbit small saphenous vein.
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CHAPTER 1
RECEPTOR POPULATIONS OF THE RABBIT 
SMALL SAPHENOUS VEIN AND THE 
SAPHENOUS ARTERY
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INTRODUCTION
Receptor populations
At the start of the 20th century very little was known about the intricacies of 
cardiovascular function though adrenaline had been shown to induce pressor responses 
in pithed cat preparations (Dale, 1906). Dale had also managed to block this pressor 
response using certain ergot alkaloids, therefore giving the first early signs that there 
may be more than one class of receptor present. Four years later Barger & Dale (1910) 
were able to compare agonist potency ratios using a series of catechols which were 
available at this time. Together with reasonably selective antagonists they produced 
evidence suggesting the presence of receptor subdivision. Noradrenaline as opposed to 
adrenaline had also been demonstrated as the substance most effective at mimicking the 
effects of sympathetic nerve stimulation. However, it was not until 1948 that any real 
progress was made when Ahlquist (1948) found two distinctly different orders of 
potency for a series of catecholamines which were used in a number of different 
preparations. From his results he suggested that there existed two types of receptor, 
the a-receptor and the (3-receptor. His dual receptor theory did not receive 
confirmation, however, until the development of (3-blockers like dichloroisoproteronol 
by Powell & Slater (1958).
The convincing evidence that further subdivision was indeed present did not come 
until the early 1970’s. Langer et al. (1971) and Starke (1972) by using preparations 
whose response was mediated via p-adrenoceptors were able to show that a - 
adrenoceptor antagonists increased transmitter overflow following nerve stimulation. 
They also showed that this was not due to changes in noradrenaline metabolism or 
uptake. The conclusion from these experiments was that noradrenaline can inhibit its 
own release via a-adrenoceptors located prejunctionally on the nerve endings. So a- 
adrenoceptors are located both pre- and postjunctionally. By further examination of 
agonist and antagonist potencies Langer (1974) proposed that these regionally distinct 
receptors were in fact functionally different from one another. He called the 
postjunctional receptors a i  and the prejunctional receptors 0C2 - Over the next few years 
this subdivision theory seem to be confirmed when the selectivity profiles for different 
tissues were shown to be highly variable (see Starke, 1977; Westfall, 1977; Vizi, 
1979).
With the development of very selective agonists and antagonists, especially the a i- 
antagonist prazosin (Cambridge et a l, 1977) the Langer theory has had to be amended. 
In vivo studies using prazosin showed this oci-antagonist to be unable to completely 
block the pressor response produced by noradrenaline (Drew & Whiting, 1979).
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Using various other selective agonists and antagonists this residual response was later 
reported to be mediated via postjunctional (X2 -adrenoceptors. Confirmation of 
postjunctional 0C2 -adrenoceptors came from McGrath et al. (1982) who blocked the 
noradrenaline-induced pressor response in pithed rabbits with the a  1-antagonist 
prazosin and the 012-antagonist rauwolscine (Weitzell et al., 1979). He showed that 
combining the antagonists produced a greater inhibition than either antagonist alone.
Trying to show the unequivocal existence of postjunctional 0C2-adrenoceptors in 
vitro, by showing susceptibility to rauwolscine and resistance to prazosin, proved to be 
a lot more difficult. The vast majority of preparations studied, especially the arteries, 
have been shown to be sensitive to prazosin (McGrath, 1982). Evidence though for the 
presence of OC2-adrenoceptors has been available from 1981 when DeMay & Vanhoutte 
reported their existence in the canine saphenous and femoral veins. This result led to 
many further in vitro studies, most of them concentrating on venous preparations where 
it had been easier to show an «2 component. However even in preparations like the 
rabbit saphenous vein which has been shown to have a large 012-adrenoceptor 
population (Alabaster et al., 1985; Schumann & Lues, 1983) there still exists 
susceptibility to prazosin. So it has been difficult to find preparations which consist of 
a homogenous population of postjunctional (X2 -adrenoceptors, though (Daly et al., 
1988a) reported the rabbit ear vein to be one such vessel.
The search for ot2 -adrenoceptors on the arterial side of the vasculature has proven 
even more difficult, though some success has been achieved using human vessels. The 
reason for this success can be inferred from results obtained by Neilsen et al. (1989). 
Using human arteries of various diameters they found that as the vessel diameter 
decreased then the a 2-adrenoceptor mediated response increased. This suggested that 
the more peripheral a vessel was the greater was its a 2 -adrenoceptor population. If true 
this would explain the difficulties encountered when looking for oc2 -adrenoceptors in 
the relatively large conduit arteries of the rabbit and rat
Apart from the prevalence of a i -  and 0C2 -adrenoceptors existing on the same 
preparation and the size of vessels used for in vitro work there is one more possible 
reason for the difficulty in demonstrating CC2-adrenoceptors in isolated blood vessels. 
This is the absence of humoral agents normally present in the intact animal. Agents 
such as angiotensin II have been implicated as being necessary for the expression of 
ot2 -adrenoceptors in vitro (Schumann & Lues, 1983). All these difficulties have been 
made worse by the as yet tentative theory that further subdivisions of the a i-  and (X2- 
adrenoceptors exist. A number of subdivisions have been suggested and each of these 
are considered on merit by McGrath et al. (1989).
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Aims of the study
To study the receptor populations of two vessels, the small saphenous vein and the 
saphenous artery, both from the rabbit. Initially this involved exposing each 
preparation to a wide range of noradrenaline concentrations to find comparative values 
for this agonist's concentration threshold and potency in the two vessels. Image 
analysis has been proposed as a less invasive technique than other in vitro methods and 
therefore should, in theory, produce responses more like that found in the intact animal. 
If this is so then it should help the expression of any (X2 -adrenoceptor populations 
present in each vessel, since a 2-adrenoceptors have been demonstrated more readily in 
vivo than in vitro.
Schumann & Lues (1983) and Daly et al. (1988a) found that rabbit saphenous vein 
had a mixed population of a i-  and a 2 -adrenoceptors, while Alabaster et al. (1985) 
stated that there were only a 2-adrenoceptors postjunctionally. A similar examination 
using image analysis of the a-adrenoceptor population in this preparation would use 
agonists which were selective for the (X2-adrenoceptor, i.e. BHT-920 and UK-14304. 
The constrictor response produced by these agonists should be selectively blocked by 
the addition both of the a  i-adrenoceptor antagonist prazosin and/or the 0C2 - 
adrenoceptor antagonist rauwolscine. Noradrenaline, an ai/(X2 -agonist, would also be 
exposed to prazosin and rauwolscine in this vessel.
The effect of angiotensin II, a humoral agent suggested as necessary for the 
expression of a 2 -adrenoceptors in this preparation (Schumann & Lues, 1983), would 
also be studied in combination with the agonists noradrenaline and UK-14304. 
Responses produced by the addition of angiotensin II with each of these two agonists 
should be blocked with prazosin and/or rauwolscine. This would show whether the 
inclusion of angiotensin II causes any difference in the potency of the agonists or the 
antagonists.
As a comparison to the vein, the rabbit saphenous artery will also undergo the same 
rigorous examination of its receptor population, more traditional in vitro methods (e.g. 
cut-rings) having shown that the a-adrenoceptors in this vessel are mostly of the oci- type. 
However its constrictor response to the a,2 -adrenoceptor agonist UK-14304 can be 
enhanced by the presence of angiotensin II (Dunn et al., 1989), this extra response 
being sensitive to the a 2-antagonist rauwolscine. Therefore as well as examining the 
artery’s receptor population, the effect of angiotensin II when the vessel is constricted 
with either noradrenaline or UK-14304 should be looked at. The effect of prazosin 
and/or rauwolscine on this response should also be studied. Image analysis would, 
therefore, not only help to show any increased response more clearly but would also
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help to prove whether it really was due to the expression of a quiescent population of 
postjunctional a 2-adrenoceptors (Dunn et al., 1989).
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MATERIALS AND METHODS
Receptor populations of rabbit small saphenous vein and saphenous artery
The usual initial periods of equilibration were punctured by the 5 minute addition of 
a dose of O.ljiM of whatever a-adrenoceptor agonist was to be used that day. 
Altogether three a-adrenoceptor agonists were used for the saphenous vein, BHT-920 
& UK-14304 which are a 2 -agonists and noradrenaline which is an a i- /a 2 -agonist. 
Only noradrenaline was used in the study of the saphenous artery.
For each agonist cumulative concentration response curves (0.01 pM to 10 jiM, in 
1.0 log unit steps) have been constructed to measure the threshold concentration and 
maximum response for each agonist. These curves were plotted on a graph with the 
contractile response (width decrease) on the y-axis and the agonist concentration 
(Molar) on the x-axis. From this concentration response curve the EC40 (agonist 
concentration required to produce 40% of the maximum constriction) was found and 
this was the concentration used in the study of the receptor populations. In practice this 
was found to be 10 nM for all the agonists used in both the small saphenous vein and 
saphenous artery.
The main experiment started with the arbitrary control period followed by two 
separate 1 0  minute additions of this EC4 0  agonist dose with accompanying wash-out 
periods. The magnitude of the second addition of the agonist was measured and 
referred to as 100%. Once this response had been established then two antagonists 
were given in addition to each agonist.
The two antagonists used were prazosin (100 nM), an a  1-antagonist, and 
rauwolscine (10 nM), an a 2 -antagonist. These were added on their own twice and 
then together once, each time for 10 minutes, to see what effect they had on the 
constrictor response. To see their full effect the antagonists had to be given for 30 
minutes on their own before being combined with the agonist to allow sufficient time 
for diffusion through the vessel wall. These 30 minute periods were stored at a slower 
frame speed of 1 frame/10 seconds to save on disc space. The maximum constrictor 
response produced in the presence of both agonist plus antagonist(s) was calculated and 
expressed as a percentage of the response to the agonist on its own, i.e. the 100% 
value. The full protocol is tabulated below, showing the duration of each drug addition 
together with the frame speed at which it was recorded, plus details of which drug was 
added at which time.
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Table 2: Standard protocol for examination of agonist + antagonists potencies in the 
rabbit small saphenous vein and saphenous artery.
Time (Mins) Frame speed Protocol Additional information
0-1 1/3 secs Krebs control period
1-11 1/3 secs agonist BHT or UK or NA
11-21 1/3 secs Krebs wash-out
21-31 1/3 secs agonist BHT or UK or NA
31-41 1/3 secs Krebs wash-out
41-71 1/10 secs 1st antagonist prazosin or rauwolscine
71-81 1/3 secs agonist+lst antagonist two drugs present
81-91 1/3 secs 1st antagonist agonist washed out
91-101 1/3 secs agonist+lst antagonist two drugs present
101-111 1/3 secs 1st antagonist agonist washed out
111-141 1/10 secs both antagonists prazosin + rauwolscine
141-151 1/3 secs both antagonists + agonist three drugs present
151-161 1/3 secs Krebs final wash-out
Mean values for percentage change in width from a few experiments were found 
and expressed in the form of histograms with accompanying error bars. Differences 
between means were considered statistically significant if P<0.05 for paired 
observations (Student t test).
One further aspect studied with respect to the receptor populations of the rabbit 
small saphenous vein and saphenous artery was the effect of Angiotensin II (All) on 
the expression of its postjunctional ct2 -receptor populations. These experiments 
involved using a similar protocol to the one tabulated above with AD being added firstly 
with the agonist alone and then in combination with the agonist plus the antagonist(s). 
Noradrenaline and UK-14304 were the agonists used at various concentrations ranging 
from 1-100 nM. The antagonists were prazosin (100 nM) and rauwolscine (10 nM), 
with rauwolscine always being added first in the vein and when using noradrenaline in 
the artery. When UK-14304 was the agonist used in the artery then it was prazosin
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which was added first. The All concentration was also varied for the vein (5-50 nM) 
and for the artery (1-10 nM) throughout this series of experiments.
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RESULTS
As explained briefly in the methods each experiment begins with a series of 20 
photographs which are the so-called "control period". The values for length and width 
of the preparation over these first 20 photographs are averaged for each separate 
segment on the blood vessel and it is upon these values that all subsequent dimensional 
changes are based. Any increase or decrease from these average control values are 
displayed on the resultant graph as percentage changes, a negative percentage being a 
decrease in the length or width of the blood vessel and vice versa. These percentage 
changes in width and length are displayed on the y-axis, while the x-axis shows the 
duration of the experiment, in minutes or seconds. Time zero is designated to be at the 
end of the control period, i.e. the 20th photograph.
Figure 4 is an example of the type of graph which is obtained using this image 
analysis technique. For simplicity the graph shows only one segment from a section of 
rabbit small saphenous vein, with the resultant width and length changes involved 
when exposed to two separate 10 minute additions of noradrenaline (10 nM). All 
future experiments will show results obtained from more than one segment, with each 
trace therefore containing more than one line representing the individual width changes 
for each segment.
The experiment shown in figure 4, like all subsequent experiments, begins with a 
control period. Each addition of noradrenaline is proceeded by a 10 minute wash-out 
period with Krebs. Noradrenaline at this dose has caused a decrease in both the width 
and length of the vessel, as can be seen by the sharp downward direction of the trace. 
Both additions of this vasoconstrictor has resulted in a similar magnitude of response 
for both length and width. Removal of noradrenaline results in a swift return of the 
dimensions to just below the baseline. The width has been decreased by about 24% 
and the length by about 4%, the width change being of a much greater magnitude than 
the corresponding length change. This was found to be the case in the vast majority of 
experiments undertaken, the length changes being not only small but so highly variable 
as to make it extremely difficult to draw any sensible conclusions from them. 
Therefore results quoted in this and the proceeding chapters will refer to changes in the 
width of the blood vessel only.
Referring back to figure 4 it is obvious that the trace is not smooth but is seen to 
consist, even under steady conditions, of a series of small and erratic variations for 
both the width and the length. This means that the image analyser (Magiscan) is not 
picking up a constant value for either of these parameters at any time during the 
experiment. The reason behind this "background noise" and the small and inconsistent 
length changes will be examined in further detail in the general discussion.
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Figure 4
The percentage length and width changes, with respect to a one minute control 
period, caused by intraluminally-applied noradrenaline (10 nM) in one segment of the 
isolated rabbit small saphenous vein. Each 10 minute addition of noradrenaline is 
followed by a 10 minute wash-out period.
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The area under investigation, using image analysis, was the receptor populations of 
two vessels from the rabbit, the saphenous artery and initially the small saphenous 
vein. Previous in vitro work has been performed on these same preparations using the 
more traditional techniques discussed in the introduction (e.g. cut-rings). This has laid 
a groundwork of results by which the image analysis data can be compared.
Noradrenaline potency in the rabbit small saphenous vein and saphenous artery
As a starting point in the examination of the receptor populations of the two vessels 
the threshold and potency for noradrenaline, a proven OC1/OC2 agonist in these 
preparations, has been determined by constructing cumulative concentration response 
curves. Concentrations as low as 0.01 pM were given to try and induce a constriction 
with each further dose being ten times stronger than the previous one. Initial studies 
have shown that for noradrenaline the maximum constriction induced by each dose was 
reached in less than 5 minutes after its addition. Therefore successive doses were given 
at 5 minute intervals.
Figure 5 represents a typical result obtained using the saphenous artery. The trace 
shows the response of two adjacent segments from the centre of the isolated vessel. 
Noradrenaline was applied intraluminally only, with the initial 20 photograph control 
period being followed by a further 5 minute control period. This procedure involved 
switching from one reservoir to another both containing identical Krebs solutions. The 
purpose of this was to show whether the mechanics involved in switching between two 
different reservoirs had any effect on the dimensions of the vessel. In fact it was 
shown to have no significant effect.
After the control period the vessel was exposed to 1 pM noradrenaline, the first 
concentration shown to cause a measurable decrease in the width of the vessel. 
Subsequent increments in the concentration caused a steady decrease in the width, a 
notable exception to this being the second noradrenaline concentration to be given. 
This dose of 10 pM caused the width of the vessel to increase by about 10%, further 
increments in the concentration resuming the pattern of vasoconstriction. This dilation 
caused by 10 pM noradrenaline was not a result consistently seen, though neither could 
it be disregarded as a one off. Quite often in the construction of concentration response 
curves there would be one dose which did cause either no constriction at all or even a 
small dilation. Reasons behind this will be examined in the discussion. A maximum 
constriction was obtained at a concentration of 10 }iM which caused the external 
diameter of the vessel to decrease by over 50%. Switching the vessel back to Krebs 
caused it to dilate to a width greater than seen initially during the control period. 
However, if the response to the final wash-out was averaged out over a number of such
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Figure 5
Cumulative concentration response curve for the intraluminal application of 
noradrenaline (1 pM to 10 pM, 1.0 log unit increments) in the rabbit saphenous artery. 
Trace shows two adjacent segments from the same preparation. Experiments starts 
with a 5 minute control followed by 5 minutes of each noradrenaline concentration 
before the final 10 minute wash-out period. The y-axis represents the percentage 
change in width caused by the drug.
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experiments then, in general, the width of the vessel did return to a value which was 
close to the initial baseline.
Figure 6 shows the corresponding cumulative concentration response curve 
obtained using the rabbit small saphenous vein. The protocol was exactly the same as 
that for the artery except that here three segments instead of two were analysed. Again 
no significant width change was seen when switching between the two separate Krebs 
reservoirs. The first noradrenaline concentration to induce a measurable constriction 
was again 1 pM. Subsequent increments in concentration led to further reductions in 
the width though these decreases were small until the concentration reached 10 nM. 
From there the width decreased rapidly, producing a maximum constriction of over 
40% at a concentration of 10 |iM. Some of the submaximal concentrations used 
produced constrictions which were not maintained, since the vessel was seen to slowly 
dilate before the next dose was given. Washing out the noradrenaline from the small 
saphenous vein resulted in all three segments returning to very .near their baseline 
values.
There existed a wide variation in the response between the different segments in the 
small saphenous vein, especially at the higher concentrations. This was something 
which was seen to a more limited degree in the saphenous artery trace shown (Fig. 5), 
though, in general, the artery was not any more or less likely to display this segmental 
variability. Possible reasons for this longitudinal variability will be given in the general 
discussion.
A series of these cumulative concentration response curves were constructed for 
both the artery and the vein. Figure 7 shows the mean values for 5 of these curves 
using the small saphenous vein together with their standard error values. Also included 
for comparison is the average responses obtained using the cut-ring method in the 
saphenous vein. The shape of the two curves are similar at the higher concentrations 
(>50 nM), with the maxima for both the image analysis and the cut-ring method being 
achieved at a concentration of approximately 10 [iM. However, this image analysis 
method exposes an extra component at the lower noradrenaline concentrations which is 
not seen using the cut-ring technique. This difference in sensitivity is present at 
concentrations below 50 nM and causes a profound shift in the lower part of the curve. 
The noradrenaline concentration threshold, which using the cut-ring method is 5 nM, 
has been reduced by a factor of 3000, to 1 pM, with image analysis. Results from the 
saphenous artery also showed a similarly increased sensitivity with image analysis over 
the cut-ring method when using noradrenaline as the constricting agent.
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Figure 6
Cumulative concentration response for the intraluminal application of noradrenaline 
(1 pM to 10 pM, 1.0 log unit steps) in the rabbit small saphenous vein. Trace shows 
three segments from the same preparation. Experiments starts with an extra 5 minute 
control period followed by 5 minutes of each noradrenaline concentration before the 
final 10 minute wash-out period. The y-axis represents the percentage change in width 
caused by the drug.
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Figure 7
A comparison between the cumulative concentration response curves for 
intraluminally-applied noradrenaline (1 pM to 10 jiM, 1.0 log unit steps) obtained with 
J image analysis and the cut-ring method in the rabbit small saphenous vein. Results are 
j expressed as a percentage of the maximum response.
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Receptor populations of the rabbit small saphenous vein and saphenous artery
From the concentration response curve a submaximal dose, equal to 10 nM, was 
selected as the agonist concentration to be used in the study of the receptor populations 
of both the saphenous artery and vein. This dose was approximately 40% of the 
maximum. There has been some disagreement, especially with the vein (Daly et al., 
1988b; Alabaster et al., 1985), as to the presence and influence of postjunctional 0C2- 
adrenoceptors in these preparations. The protocol employed to study the receptor 
populations initially involved obtaining a steady constrictor response to the agonist (see 
Fig. 8). This meant adding the agonist at least twice to make sure the response was 
consistent in magnitude. Figure 8 shows the result of an experiment on the small 
saphenous vein in which noradrenaline was the agonist applied, though a similar 
response was obtained with the other two agonists used, i.e. BHT-920 and UK-14304 
(both (X2 -agonists).
After a steady response was obtained the vessel was selectively antagonised with 
either prazosin (ai) and/or rauwolscine (0C2), each of the antagonists being given for 30 
minutes on their own before being combined with the agonist. Neither of the 
antagonists had any effect on the dimensions of the vessel when given on their own for 
this initial equilibration period.
In the case of the small saphenous vein addition of either prazosin or rauwolscine 
was able to cause a sizeable reduction in the magnitude of the vasoconstriction induced 
by the agonist. The degree of the antagonism varied depending on which agonist and 
which antagonist(s) were given. A series of experiments employing the same protocol 
as that seen in figure 8 was completed using the three agonists, noradrenaline, BHT- 
920 and UK-14304 and the two selective antagonists prazosin and rauwolscine. 
Results were grouped, means calculated and the data expressed in the form of 
histograms (fig. 9). The magnitude of the percentage decrease in width for the second 
addition of the agonist was referred to as 100%. Responses after addition of the 
antagonists were compared to this 100% value and included in the histogram along with 
their standard errors. Looking firstly at noradrenaline it can be seen that prazosin and 
rauwolscine, at their respective concentrations, were equally effective at blocking the 
response to this agonist. Addition of either antagonist reduced the constriction by just 
under two thirds. Combining the antagonists caused a further reduction leaving just 
over 10% of the original constriction.
When the 0C2 -agonists, BHT-920 and UK-14304, were used then prazosin was 
much less effective as an antagonist. It reduced BHT-920's response by 30% and UK- 
14304's response by only 12%. The reduction with UK-14304 was found not to be 
statistically significant. Rauwolscine was only tested on its own against UK-14304, it
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Figure 8
Effects of the a  1-antagonist prazosin (100 nM) without and then with the 0C2 - 
antagonist rauwolscine (10 nM) on the constriction produced by the ai/<X2 -agonist 
noradrenaline (10 nM) in the rabbit small saphenous vein. All drugs were given 
intraluminally. Trace shows the percentage change in width for two segments from the 
same preparation.
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Figure 9
Effects of the antagonists prazosin (ai, 100 nM) and/or rauwolscine (<X2,10 nM) 
on the constriction produced by three agonists, noradrenaline (oci/a2), UK-14304 (0C2) 
and BHT-920 (CC2 ) (all 10 nM) in the rabbit small saphenous vein. All drugs were 
applied intraluminally with the mean response expressed as a percentage to that 
obtained using the agonist alone.
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being the more selective of the a 2-agonists, and was able to reduce the constriction by 
roughly a half. This degree of antagonism is not as big as that produced against 
noradrenaline which is an oci/(X2 -agonist. Addition of prazosin plus rauwolscine 
against both UK-14304 and BHT-920 caused a similar degree of antagonism, the 
residual response remaining each time being equal to one third of the original response. 
The magnitude of this residual response was greater than that seen when noradrenaline 
was the agonist used.
A less detailed investigation was also conducted on the rabbit saphenous artery 
using the same protocol as that seen in figure 8. Previous studies of its receptor 
population has shown it to be composed of mostly ai-adrenoceptors postjunctionally, 
prazosin being much more effective than rauwolscine as an antagonist. Noradrenaline 
was the only agonist to be applied, the response it produced being blocked by prazosin 
and rauwolscine, the same two antagonists as that used for the small saphenous vein. 
Both the agonist and antagonists concentrations were the same as had been used for the. 
vein. The results were grouped and displayed as a histogram (see fig. 10). Although 
not enough data was collected to be able to do rigorous statistical analysis on the results 
(i.e. no error bars) the variations seen between different experimental days were small 
and the histogram does show a fairly clear-cut difference in the potencies of the two 
antagonists.
Prazosin, the ai-antagonist, has blocked about 95% of the constriction, while 
rauwolscine, the (^-antagonist, has blocked only about 55% of the constriction. 
Therefore as with previous findings prazosin has been shown to be much more 
effective as an antagonist, against noradrenaline, than rauwolscine in the saphenous 
artery. Addition of both antagonists together almost completely abolished the induced 
constriction. This result was not one found with the small saphenous vein where 
addition of both antagonists still left a small residual response equal to just over 10% of 
the original response. Whether this residual response in the small saphenous vein was 
due to another type of postjunctional receptor or because the antagonist concentrations 
were not high enough has not been investigated.
Effect of angiotensin II on responses in rabbit saphenous vein and saphenous artery
The effect of angiotensin II on the potency of both noradrenaline and UK-14304 
and its effect on the ability of prazosin and rauwolscine to block this constriction was 
the final area of investigation. Angiotensin II was used in both the small saphenous 
vein and the saphenous artery, its action previously being analysed by Daly et al. 
(1988d) and Schumann & Lues (1983) in the vein and Dunn et a l  (1989) in the artery. 
In the artery it was found that angiotensin II could enhance responses produced by low
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Figure 10
Effects of the antagonists prazosin (ai, 100 nM) and/or rauwolscine (<X2 , 10 nM) 
on the constriction produced by the agonist noradrenaline (ai/(X2 , 10 nM) in the rabbit 
saphenous artery. Drugs were applied intraluminally, with the mean expressed as a 
percentage to that obtained using the agonist alone.
47
concentrations of UK-14304 and that this extra response was susceptible to 
rauwolscine, therefore indicating it to be due to (X2 -adrenoceptors. In the vein it was 
suggested that the presence of angiotensin II was necessary for the expression of 
postjunctional 0C2-adrenoceptors.
Having already seen the existence of (X2 -adrenoceptors in both the vein and the 
artery angiotensin II was tested to see if it could expose any further as yet quiescent 0C2- 
adrenoceptor population in these vessels. Figure 11 is an example of the result which 
was typically seen in both the vein and the artery. A steady response was obtained to 
the addition of a submaximal concentration of the agonist (<10 nM). This was 
followed by addition of angiotensin II (5-50 nM) on its own which caused a larger 
constriction than the agonist. Dunn et al. (1989) has stated that the constriction induced 
by angiotensin II was only transient with the tension returning to baseline after 15 
minutes. This was not seen with image analysis where addition of angiotensin II 
caused a constriction which was at least partly maintained.
Responses after this point in both the vein and the artery were very inconsistent and 
hard to interpret due to the baseline shift caused by the addition of the angiotensin II. 
However, in general angiotensin II was seen to have no effect on the levels of 
constriction produced by either noradrenaline or UK-14304 in the artery or the vein. 
To test the second proposed action of angiotensin II, i.e. its ability to expose a 
quiescent population of cx2-adrenoceptors, needed the introduction of rauwolscine (0C2- 
antagonist) and prazosin (a  1-antagonist). These antagonists were used at 
concentrations of 10 nM and 100 nM respectively. In theory if angiotensin II does 
expose a quiescent population of ot2 -adrenoceptors then the extra response should be 
more sensitive to rauwolscine. In practice, with both the artery and the vein, 
rauwolscine and prazosin were not any more or less effective than they had been in the 
absence of angiotensin II. So angiotensin II did not enhance the response to either of 
the agonists used and did not expose a quiescent population of (X2-adrenoceptors, since 
the potencies of both agonists and antagonists were unaltered.
48
n orad ren a lin e
(1 nM) A n gio ten sin  (5 nM) [jy
R auw olscine (10 nM)
Prazosin (100 nM)
-A - \
T3
-121
Time (M inutes)
70
Figure 11
Effect of angiotensin (5  nM) on the constriction produced by noradrenaline (0C1/ 0C2 - 
agonist, 1 nM) alone, and then in combination with firstly rauwolscine (a2-antagonist, 
10 nM) and then with rauwolscine and prazosin (ai-antagonist, 100 nM). Drugs were 
applied intraluminally. Trace shows the percentage change in width for two segments 
from the same preparation.
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DISCUSSION
Noradrenaline potency in the rabbit small saphenous vein and saphenous artery
Concentration response curves constructed in the saphenous artery and the small 
saphenous vein, both from the rabbit, have shown a similar sensitivity to the ai/a ,2- 
agonist noradrenaline (Figs. 5 & 6). Reduction in the width of these vessels have been 
seen using concentrations as low as 1 pM, which represents values well within the 
normal physiological concentration range. Using image analysis, as compared to other 
in vitro methods, has meant a large increase (-3000 fold) in the noradrenaline 
concentration threshold for these preparations. Results using cut-rings have reported 
the noradrenaline concentration threshold to be in the region of 5 nM (Daly et al., 
1988b; Figure 7).
Quite often a dilation was elicited by one of the lower noradrenaline concentrations 
comprising the dose response curve. It was not necessarily the same concentration, 
therefore ruling out the possibility that one of the reservoirs was being contaminated in 
some way. Nor could it be put down to incorrectly made-up solutions since its 
frequency was too great. Often it would be the second dose to be added, suggesting 
that the tissue might be hypersensitive to the first dose of the agonist in the 
concentration response curve. This seems unlikely since all experimental days started 
with an initial submaximal dose of the agonist, encapsulated by extended periods of 
equilibration before the experiment proper was started. This was found to minimize 
changes in the sensitivity of the preparation to further additions of the agonist, and is 
similar to the method used by Ruffolo et al. (1979).
All agonist concentrations produced constrictions which at times were not fully 
maintained, but instead crept slowly towards baseline. This has not been widely 
reported elsewhere though Daly et al. (1988b) did find that UK-14304 concentrations 
took longer to reach their maximum when compared to their noradrenaline counterparts. 
So differences do exist among agonists with regard to their constriction characteristics. 
The general technique employed when using cumulative concentration response curves 
is to switch to the next concentration as soon as the previous one has reached its 
maximum. This would preclude experimenters from seeing the small dilations present 
with image analysis where each concentration is added for a set time (5-20 minutes). 
Those preparations which did show unmaintained constrictions tended to display them 
throughout the day, even after addition of selective antagonists. A depletion of some 
factor is one possible reason for this phenomenon, though what this factor could be 
remains unclear. Possible candidates are calcium or some second messenger involved 
in the contractile process. A more likely cause is uptake or metabolism of the
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contractile agent by the neuronal processes. Differences seen between experimental 
days could thus be explained by variations in the density of this neuronal innervation.
Image analysis has not shown any discrepancy, when compared to other in vitro 
techniques, as far as the noradrenaline concentration required to obtain a maximal 
constriction, this being a value of 10 pM for both the small saphenous vein and 
saphenous artery. The effect on the width of the vessel at this concentration was 
variable between different experimental days, though decreases of as much as 50% 
were not uncommon. This large decrease in diameter, when combined with the smaller 
reductions in length, means in effect that the volume inside the vessel has been reduced 
by well over half. What also is apparent is that vessels such as the small saphenous 
vein and artery are composed mostly of circular smooth muscle as opposed to 
longitudinal muscle. This conclusion being reached from the differences in the 
magnitude of changes seen for the width and length respectively.
Receptor populations in the rabbit small saphenous vein
Three agonists were used to study the receptor populations, all employed at an 
EC4 0  concentration of 10 nM. These were the a 2 -agonists BHT-920 (Kobinger & 
Pichler, 1980) and UK-14304 (Cambridge, 1981), and the ai/(X 2 -agonist 
noradrenaline (Furchgott, 1972). Examination of agonist potencies by Daly et al. 
(1988b) in the saphenous vein has shown that the order of potency was UK-14304 > 
noradrenaline > BHT-920. Schumann & Lues (1983) also found noradrenaline to be 
more potent than BHT-920 in this vessel. However, using image analysis, potencies 
of the (X2 -agonists BHT-920, UK-14304 and noradrenaline (cci/(X2) were similar in the 
small saphenous vein. All these results suggest the existence of a postjunctional OC2- 
adrenoceptor population mediating the contractile response in this vein. The 
disagreement between the different techniques is therefore not the presence, but the 
overall influence of this 0C2-adrenoceptor population.
Studies using the selective ai-antagonist prazosin (Cambridge etal., 1977; Honda 
etal., 1985) and the (^-antagonist rauwolscine (Weitzell et al., 1979) provided further 
evidence as to the composition of the postjunctional adrenoceptor populations of the 
small saphenous vein.
Using image analysis the 0C2 -agonists, BHT-920 and UK-14304, and even the 
<Xl/oc2 agonist, noradrenaline, have all shown considerable resistance to the high 
concentration of prazosin used (see Fig. 9). This points to the existence of 
postjunctional a 2 -adrenoceptors mediating the contractile response. Results using the 
equivalent concentrations in cut-rings (Daly et al., 1988b) and helical strips (Schumann
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& Lues, 1983) do not concur. Instead prazosin was shown to abolish completely the 
constrictions produced by any of these agonists, therefore suggesting that 0C2 - 
adrenoceptors cannot express responses on their own, i.e. are dependant on the 
presence of ai-adrenoceptors. Alabaster et a l  (1985), on the other hand, stated that 
prazosin at concentrations up to 300 nM had absolutely no effect on the responses 
produced by these agonists, suggesting the saphenous vein consists of a homogeneous 
population of a 2 -adrenoceptors.
Sensitivity to the addition of the selective 0C2-antagonist rauwolscine can also be 
considered as evidence for the presence of (X2 -adrenoceptors. The results with the 
saphenous vein (Fig. 9) show that rauwolscine does substantially reduce the response 
to UK-14304 and noradrenaline, being more effective against the latter. This 
antagonist is not able to abolish the response completely at the concentrations used. 
The presence of a rauwolscine-resistent component, coupled with the antagonists 
potencies against noradrenaline point to a mixed population of a i -  and 0C2 - 
adrenoceptors in this preparation.
Receptor protection experiments, performed using the irreversible antagonist 
phenoxybenzamine (Furchgott, 1972), on the saphenous vein (Daly e ta l , 1988c) also 
point to a mixed population. This antagonist has been shown at low concentrations to 
be specific for the a  1-adrenoceptor (Borowski et a l, 1977). By combining this 
antagonist with rauwolscine it was possible to isolated the ct2-adrenoceptor, since the 
remaining response to noradrenaline was insensitive to prazosin and sensitive to 
rauwolscine.
Combination of both antagonists against all three agonists showed an inability to 
completely block the response, especially with the (X2 -agonists where one third of the 
response remained. The reason behind this could be the comparatively low 
rauwolscine concentration (10 nM) which was employed during the series of 
experiments. Image analysis has exposed an extra component in its concentration 
response curve with greater responses seen at concentrations below 10 nM. If this 
extra component is attributed to the recruitment of (X2-adrenoceptors then the relatively 
low concentration of rauwolscine may be insufficient to block the whole CC2- 
adrenoceptor population. The fact that rauwolscine and prazosin were equally effective 
against noradrenaline, even though rauwolscine's concentration was ten times lower 
does suggest that oc2 -adrenoceptors predominate in the small saphenous vein.
Reasons for the wide disparities seen with image analysis as compared to other in 
vitro methods are not clear. One may be simply that experimenters are using 
anatomically different regions of the saphenous vein. Another may be that the more
52
invasive conditions present when setting up rings or strips may in some way effect the 
subsequent expression of the (X2-adrenoceptor population.
Effect of angiotensin II on receptor populations in rabbit small saphenous vein
Angiotensin II is one of many pharmacological stimulants which have been 
introduced in the study of the receptor populations of isolated blood vessels. 
Substances like Bay K 8644 (Sulpizio & Hieble, 1987) and prostaglandin F2a (Furuta, 
1988), also classed as stimulants, have been shown to enhance responses to BHT-920 
which were prazosin-resistent and rauwolscine-sensitive, in canine saphenous artery 
and portal vein respectively. Studies with angiotensin II in the saphenous vein P a ly  et 
al., 1988d; Schumann & Lues, 1983) have shown this substance to also be one capable 
of enhancing responses (via postjunctional ot2 -adrenoceptors) when exposed to 
noradrenaline and BHT-920 respectively. Angiotensin II had no effect on a p  
adrenoceptors and only effected a 2 -adrenoceptors when they have been isolated.
My examination in the small saphenous vein, using noradrenaline or UK-14304 as 
the agonists, has endeavoured to find any link between the renin-angiotensin system 
and postjunctional a-adrenoceptor function. No such link has been found using image 
analysis. Previous reports of enhanced responses to agonists, via the introduction of 
quiescent (X2 -adrenoceptor populations in the contractile process, has not been seen. 
Potencies of the two agonists and the antagonists prazosin and rauwolscine were no 
different from that seen using image analysis in the absence of angiotensin II. The 
reason for this- apparently negative result may be that this less invasive technique has 
already exposed the ot2 -adrenoceptor population, shown by the earlier reported 
antagonist potencies. Therefore the introduction of angiotensin II can have no further 
effect on the response.
Addition of angiotensin II has up until now been shown to exert a transient 
constriction in this vessel (Daly et al., 1988d). With image analysis, and using 
identical concentrations, this constriction was at least partly maintained and caused 
baseline shifts of as much as 20%. Reasons behind this may be related to the widely 
different experimental conditions (e.g. pressure and tension) which image analysis 
confers upon the preparation as opposed to the more traditional techniques. In fact on 
many of the experimental days the constriction induced by angiotensin II was greater 
than that produced by either of the agonists, using identical concentrations.
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Receptor populations in the rabbit saphenous artery
Previous in vitro studies examining agonist potencies have shown this vessel to 
have a predominance of ai-adrenoceptors postjunctionally (Dunn et al., 1989). The 
similarity in potency of prazosin in this vessel as compared to other vessels with largely 
oti-adrenoceptor populations (Docherty et a l, 1981; Hieble et a l, 1982; Kaposci et al, 
1987) also indicates this vessel to contain mostly ai-adrenoceptors. Further proof is 
provided by the fact that rauwolscine (10 |iM), a selective (X2-antagonist, is largely 
ineffective in this vessel when constricted with noradrenaline.
Using image analysis the vessel was studied with noradrenaline (OC1/OC2 ) as the 
agonist and prazosin (ai) and rauwolscine ((X2) as the antagonists (see Fig. 10). Like 
previous results prazosin was more effective than rauwolscine in blocking the 
noradrenaline-induced constriction, however that is where the similarities stop. 
Looking at results from the different experimental techniques, using the same drug 
concentrations, it seems that image analysis is the only one to show a rauwolscine- 
sensitive and small prazosin-insensitive response in this vessel. The absence of the 
prazosin-resistent response previously had been accounted for by the theory that there 
was some interaction between the a j-  and (X2 -adrenoceptors. This interaction meant 
that the (X2 -adrenoceptors could not express responses on their own after blockade of 
the ai-adrenoceptors with prazosin.
Image analysis results suggest this to be untrue since there is a response present 
even after addition of prazosin. The fact that this residual response can be removed by 
the addition of rauwolscine suggests it to be due to <X2 -adrenoceptors. In contrast to the 
small saphenous vein, addition of both antagonists will completely abolish the response 
to noradrenaline in this vessel. Therefore it appears that only a i-  and (X2-adrenoceptors 
are involved in the contractile process in this artery, unless these ‘selective’ agonists 
exert their effect via another type of receptor(s) which seems unlikely.
Effect of angiotensin II on receptor populations in rabbit saphenous artery
Just like the saphenous vein, this preparation has been shown to alter its properties 
when exposed to angiotensin II. Under normal conditions the contractile process is 
mediated via postjunctional ai-adrenoceptors. However, using the (X2 -agonist UK- 
14304 with angiotensin II, extra responses have been seen in this tissue which are 
prazosin-resistent and rauwolscine-sensitive (Dunn et al, 1989). These responses 
were attributed to the introduction of an 0L2 -adrenoceptor population. Angiotensin II 
has also been shown to enhance responses to noradrenaline in the rat caudal artery 
(Nicholas, 1970), in the canine hindpaw (Zimmerman & Kraft, 1979), as well as many
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other arterial preparations. In the rat tail artery, which has an (X2 -adrenoceptor 
population (Templeton et al., 1989), antagonists potencies against noradrenaline have 
been altered by the presence of angiotensin II (Rajanayagam & Medgett, 1987). This is 
something which has also been seen recently in the saphenous artery (Dunn, 
unpublished). Therefore, using image analysis, the saphenous artery was analysed in 
the presence of the agonists noradrenaline and UK-14304, the antagonists prazosin and 
rauwolscine as well as various concentrations of angiotensin n.
The results were very similar to those obtained in the small saphenous vein where 
angiotensin II has had no effect on either the potencies of the agonists or the 
antagonists. These conclusions are based on an overall view of the data since 
potencies, especially prazosin’s, were highly variable after addition of angiotensin II. 
Interpretation of results were hindered by the repeated presence of large changes in the 
baseline, caused by addition of angiotensin II (see Fig. 11), which were at least partly 
maintained.
Previous in vitro studies using angiotensin II have reported a transient and 
tachyphylactic response to this drug (Dunn et al., 1989; Schumann & Lues, 1983), 
though this tachyphylaxis could be reversed by inducing tone with KC1 (Juul et al., 
1987) and is not present at all in some in vivo preparations (Bohr, 1974). The fact that 
image analysis is less invasive and is therefore more like the conditions found in vivo 
might be one reason for the maintained constrictions caused by angiotensin II seen in 
both the saphenous artery and the small saphenous vein. If this is true then it implies 
that preparations at baseline are under some degree of tone before the addition of the 
agonists and even after wash-out the tissue is still not fully relaxed. As stated earlier 
when considering the vein, this may be related to the conditions under which the vessel 
is placed with this image analysis technique.
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CHAPTER 2
ROLE OF THE ENDOTHELTUM IN THE 
RABBIT SMALL SAPHENOUS VETN AND 
SAPHENOUS ARTERY
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INTRODUCTION
Role of the endothelium: release of EDRF
Over the past 25 years the importance attached to the vascular endothelium has 
changed enormously. From being considered just as a semi-permeable membrane, it 
has now attained the status of an integral and essential working part of the functioning 
cardiovascular system. This status was initially formed by endothelial cell culture 
techniques which showed the endothelium to be involved in the reactivity of the 
vascular smooth muscle. Its many functions include extracting or metabolizing 
vasoactive substances including noradrenaline, thereby reducing its activity on the 
smooth muscle. It can convert precursors into there active form (e.g. angiotensinogen 
to angiotensin) and it also releases a factor called endothelium-derived relaxant factor 
(EDRF) which initially was shown to cause relaxation of arterial smooth muscle.
Acetylcholine, shown to cause vasodilation in many in vitro preparations, was the 
first agent to highlight the importance of an intact endothelium and the existence of 
EDRF. Studies by Furchgott et al. (1981), Furchgott (1981) and Furchgott & 
Zawadzki (1980a,b) had shown that isolated arterial preparations, precontracted with 
exogenously applied noradrenaline, could only be relaxed by acetylcholine if the 
endothelium was intact. Their studies were confined to the rabbit thoracic aorta. 
However, this finding was also confirmed in various other arteries over the next couple 
of years. Furchgott also confirmed this relaxation caused by acetylcholine was 
mediated via muscarinic receptors located on the endothelial cells.
Acetylcholine has also been cited as a vasoconstrictor in some vessels which are 
under some degree of pre-existing tone. In endothelium-intact segments of the lateral 
saphenous vein, high concentrations of acetylcholine (>100 nM) have been shown to 
produce constrictions on the noradrenaline-induced tone (McGrath et al., 1990b). This 
response has been attributed to cycloxygenase activation, via release of prostaglandins, 
since addition of the cycloxygenase inhibitor flurbiprofen will prevent these 
constrictions. This constrictor action of acetylcholine has been seen in only a limited 
number of preparations.
The next question which was asked was what exactly is EDRF? Bioassay 
experiments (Griffith et al., 1984) and so-called “sandwich” experiments (Furchgott & 
Zawadzki, 1980a,b; Furchgott et al., 1981) were two of the experimental techniques 
used to answer this question. The “sandwich” experiments involved setting up one 
vascular strip with a disrupted endothelium on a isometric transducer. Another vascular 
strip which either had an intact or a disrupted endothelium was then wrapped around
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this strip. Experiments showed that the strip attached to the transducer was only 
relaxed by acetylcholine when the second strip contained an intact endothelium. 
Therefore some factor (EDRF) was being transferred between the strips.
Bioassay experiments involved the transfer of the perfusate from an acetylcholine 
stimulated vessel with an intact endothelium to a preconstricted vessel with a disrupted 
endothelium. The perfusate was able to induce dilation in this de-endothelialized 
preconstricted strip. Both these experimental techniques helped to show that a chemical 
factor was released by the endothelium to cause vasodilation, this factor being EDRF. 
The bioassay experiments had also shown EDRF to have a short half-life, since the 
degree of dilation in the second strip could be reduced by increasing the length of the 
perfusion tubing connecting it with the intact strip. This result gives some indication 
why it has been so difficult to isolate a pure sample of EDRF.
Once EDRF’s existence had been confirmed, the next area under investigation was 
its mechanism of action on the vascular smooth muscle. The relaxations produced by 
acetylcholine are thought to be caused initially by stimulation of guanylate cyclase, 
which leads to the production of cyclic guanosine monophosphate (cGMP) and the 
activation of cGMP-dependent protein kinase in vascular smooth muscle. Evidence 
behind this came from studies where removal of the endothelium was shown to abolish 
the accumulation of cGMP as well as acetylcholine’s ability to cause vasodilation. This 
theory has been backed up by experiments using compounds which increase or 
decrease the cGMP concentration. Addition of known guanylate cyclase inhibitors will 
block relaxations to acetylcholine even in preparations with an intact endothelium 
(Holzmann, 1982). The use of nitrovasodilators, like sodium nitroprusside (Rapoport 
& Murad, 1983), in the rat aorta has indicated that with or without an intact 
endothelium these substances can cause vasodilation via the same mechanism as 
acetylcholine. In other words both endothelium-dependent, using acetylcholine, and 
endothelium-independent, using sodium nitroprusside, relaxations are mediated via 
cGMP-dependent protein phosphorylations.
While in the process of testing whether EDRF-mediated cGMP increases did 
involve direct guanylate cyclase activation Furchgott & Zawadzki (1980a,b) made 
another significant discovery. Addition of a soluble guanylate cyclase preparation into 
the lumen of several arteries along with GMP caused the catalytic activity of the 
preparation to increase, as long as the endothelium was intact. This indicates that there 
is a continuous basal release of EDRF from the endothelial cells. Adding acetylcholine 
will further increase the catalytic activity, while removing the endothelium will prevent 
any increase in the activity of the guanylate cyclase preparation.
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The effects of removing the endothelium on EDRF release can be mimicked 
chemically by haemoglobin (Martin et al., 1986b). Haemoglobin is a large protein 
which is unable to pass through the cell membrane and therefore exerts its effect on 
EDRF in the extracellular space. Its mechanism of action is not to prevent the release of 
EDRF but to bind to it once it has been released, rendering it inactive (Martin et al., 
1986a; Ignarro et a l, 1987a). Therefore haemoglobin has the ability to block the 
relaxatory effect produced by addition of acetylcholine in a preconstricted preparation. 
The addition of haemoglobin has also been shown to augment oc-adrenoceptor-mediated 
contractions in endothelium-intact preparations, presumably by inactivating the basal 
release of EDRF, therefore once again mimicking the effect of mechanical removal of 
the endothelium (Martin et a l, 1986b). Pascual et a l (1989), using a procedure where 
drug entry in rabbit aortic rings is restricted to one surface, have provided further 
evidence on haemoglobin’s site of action. They have shown that haemoglobin will 
only augment noradrenaline-induced constrictions when added via the intima and not 
when added via the adventitia.
Evidence is still conflicting as regards the functional significance of the basal release 
of EDRF with some experimenters seeming to suggest little functional significance 
(Oriowo et a l, 1987), while others give it a more influential role in the modulation of 
responsiveness of vascular smooth muscle to constrictor stimuli (Martin et a l, 1986b). 
A recent report by McGrath et a l (1990b) has stated, using rabbit saphenous artery and 
vein, that basal release of EDRF plays a more important role in the veins than in the 
corresponding artery. This conclusion might come as something of a surprise as there 
have been few reports suggesting a powerful influence of EDRF in veins. This might 
be due in part to the lack of experimental results obtained using veins, with most 
experimenters in this field concentrating on the arterial side of the vasculature.
Ever since the first early experiments suggesting the existence of an endothelial- 
dependent relaxing factor there has been much speculation on the chemical nature of 
this EDRF. The first likely candidates were arachidonic acid and its derivatives. 
Quinacrine, an inhibitor of the enzyme which produces arachidonic acid, prevents 
EDRF-mediated relaxations in a variety of blood vessels (Singer & Peach, 1983; 
Furchgott & Zawadzki, 1980). However, it was also suggested that EDRF may be a 
labile hydroperoxide or free radical intermediate product, since acetylcholine-induced 
relaxations could be blocked by substances like hydroquinone (a free radical 
scavenger). One such radical is nitric oxide (NO) and this is the substance recent 
studies have implicated as being EDRF. Palmer et a l (1987) has done a series of 
experiments showing that EDRF and NO have very similar properties, e.g. both 
produced relaxations which were blocked by haemoglobin. The possibility, however, 
that there is more than one EDRF (Vanhoutte, 1987) cannot be ruled out.
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Nitrogen-containing vasodilators, e.g. sodium nitroprusside, which effect 
vasodilation by the same mechanism as NO (stimulation of smooth muscle soluble 
guanylate cyclase; Ignarro et al., 1987a) have a clinical activity generally attributed to a 
preferential action on venous smooth muscle. This makes the lack of reports 
supporting a powerful influence of EDRF in veins even more surprising, though this 
might be partly explained by the fact that many endothelium-dependent arterial relaxants 
do not relax endothelium-intact venous preparations (Ignarro et a l, 1987b). The above 
stated clinical activity does however seem to reinforce the results by McGrath et al. 
(1990) who found basal release of EDRF to be more effective in the rabbit saphenous 
vein than in the corresponding artery.
Aims of the study
To look at the influence of the endothelium in two preparations, the rabbit small 
saphenous vein and the saphenous artery. With the less invasive image analysis 
technique it is possible to set up preparations with a lot less damage to the endothelium 
than other in vitro techniques, e.g. cut-rings. In the case of the small saphenous vein 
very little is known about the dimensional changes induced by EDRF, particularly in 
such an intact vessel and at physiological pressures. Tone would be induced with 
noradrenaline and concentration response curves for relaxation to acetylcholine and 
sodium nitroprusside established. This would provide a good comparison between an 
endothelium-dependent vasodilator (acetylcholine) and an endothlium-independent 
vasodilator (sodium nitroprusside). Differences in the potency and speed of response 
of the two vasodilators would be exposed by image analysis for each preparation. 
Most of the previous reports in this field have indicated EDRF to be mainly an arterial 
phenomenon, however this study would allow a direct comparison between the arterial 
and the venous side of the circulation in two vessels where EDRF has already been 
shown to play some kind of functional role.
In the rabbit saphenous vein it has been reported that with endothelium-intact 
preparations high concentrations of acetylcholine (>100 nM) cause transient 
constrictions. These constrictions are blocked by the addition of the cycloxygenase 
inhibitor flurbiprofen. Therefore flurbiprofen should be added along with acetylcholine 
to see if it can aid acetylcholine’s ability to relax the vein back to baseline and remove 
any transient constrictions which it causes.
The release of EDRF will be interrupted by the addition of haemoglobin, which 
binds EDRF. Initially it will only be given intraluminally. In theory, its addition 
should reduce or even abolish the basal release of EDRF, therefore making the 
preparation more responsive to noradrenaline (McGrath et al., 1990). Acetylcholine’s
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ability to relax noradrenaline-induced sub-maximal constrictions should also be limited 
or abolished by its addition. By adding haemoglobin extraluminally, in the small 
saphenous vein, it would be possible to see if this makes any difference to its 
effectiveness as an inhibitor of EDRF mediated vasodilation.
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MATERIALS AND METHODS
Role of the endothelium in rabbit small saphenous vein and saphenous artery
Using the a i / a 2 -adrenoceptor agonist noradrenaline as the constricting agent the 
role of the endothelium was explored using acetylcholine. Noradrenaline was used 
throughout at a concentration of 100 nM (ED60 value). The constriction produced by 
this dose of noradrenaline was relaxed using acetylcholine added in 1 .0  log unit 
increments from 0.1-1000 nM. From this an EC50 value was found for acetylcholine, 
i.e. dose of acetylcholine which will induce 50% of the maximum relaxation. This 
EC50 dose, which was found to be 10 nM, was then combined with noradrenaline (100 
nM) twice for 10 minutes each time to try and show a repeatable degree of relaxation by 
the acetylcholine. Each addition was followed by a 10 minute wash-out period. Using 
the vein only, the acetylcholine concentration response curve was repeated, this time in 
the presence of the cycloxygenase inhibiting agent flurbiprofen which was present 
throughout at a concentration of IjiM.
The next vasodilator used in both the artery and vein was sodium nitroprusside with 
the protocol as follows; noradrenaline (100 nM) was given for 10 minutes on its own 
and then relaxed with cumulative additions of either acetylcholine (0.1-1000 nM) or 
sodium nitroprusside (0.01-10 |iM). Both acetylcholine and sodium nitroprusside 
were added in 1.0 log unit increments at 5 minute intervals. Once the maximum level 
of relaxation had been achieved for each substance then this maximally effective dose 
was combined with the maximally effective dose of the other substance for a further 5 
minutes. After this the vessel was washed out for 5 minutes with Krebs. This protocol 
was repeated with the artery set up at a venous pressure of 13 mmHg and the vein set 
up at an arterial pressure of 100 mmHg.
Acetylcholine (10-1000 nM) was also added, using 1.0 log unit incremental steps at 
5 minute intervals, against noradrenaline (100 nM) first in the absence and then in the 
presence of the EDRF inhibitor haemoglobin (1 jiM). For both the saphenous artery 
and small saphenous vein the haemoglobin was added on top of noradrenaline for 1 0  
minutes just prior to the addition of the incremental doses of acetylcholine. In the case 
of the saphenous artery the haemoglobin was only given intraluminally, while for the 
saphenous vein experiments involved the addition of haemoglobin both intraluminally 
and extraluminally.
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RESULTS
The vascular endothelium has been shown to release EDRF which causes blood 
vessels to dilate. These results were obtained using fairly invasive in vitro techniques 
(e.g. cut-rings) which have limited the possibility of obtaining an adequate length of 
blood vessel with its endothelium intact. With the less invasive technique of image 
analysis this possibility does, in theory, exist.
EDRF has been shown to be released by the addition of acetylcholine against an 
agonist-induced constriction. Therefore the starting point in the examination of the 
influence of the endothelium involved the use of acetylcholine, with noradrenaline 
being used as the agonist. Two vessels from the rabbit were studied, the saphenous 
artery and initially the small saphenous vein.
Role of the endothelium in the rabbit small saphenous vein
Figure 12 shows the first protocol used to measure the influence of the endothelium 
in the small saphenous vein. Addition of 100 nM noradrenaline, an EC50  dose, caused 
a large enough constriction to be able to study the full relaxing power of acetylcholine. 
Cumulative doses of acetylcholine (100 pM to 1 pM) were given in 1.0 log unit steps 
against this dose of noradrenaline at 1 0  minute intervals.
The first thing to notice is the widely different sensitivities of the two separate 
segments to the addition of noradrenaline. One segment has been constricted by about 
24%, while the other has only been constricted by about 10%. This large difference is 
surprising considering that the two segments are adjacent to one another. However, the 
percentage response to the addition of acetylcholine was very similar in magnitude 
when compared to the respective magnitudes of constriction elicited in each of the 
segments. The first two doses of acetylcholine (i.e. 100 pM and 1 nM) did relax the 
vessel but only transiently, the velocity of relaxation being much greater than the 
velocity of the subsequent constriction. In general further increments in the 
concentration of acetylcholine caused constrictions which were at least partly 
maintained. The maximum level of relaxation was achieved using the highest dose of 
1 pM, which relaxed the induced constriction by about one third. An ED50  dose 
(concentration of acetylcholine which induces 50% of the maximum relaxation) was 
found to be 100 nM and this was combined twice more with the noradrenaline to try 
and obtain a steady degree of relaxation. This showed that the response produced by 
acetylcholine was repeatable and consistent.
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Figure 12
Trace shows the percentage changes in the width for two segments from the rabbit 
small saphenous vein. The vessel was constricted with noradrenaline (100 nM) and 
then relaxed by the cumulative addition of acetylcholine (100 pM to 1 |iM, in 1.0 log 
unit steps). The acetylcholine EC50  value was then added twice more against the same 
dose of noradrenaline before the final wash-out.
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The highest dose of acetylcholine which was used (i.e. 1 jiM) had been shown 
previously to be the most effective at relaxing any induced constriction, however even 
this dose was unable to relax the vessel completely back to baseline. Flurbiprofen, an 
cycloxygenase inhibitor, had been implicated as a factor which could overcome this 
problem by blocking the release of prostaglandins. So the next step was to repeat the 
acetylcholine cumulative concentration response curve, this time in the presence of 
flurbiprofen and see what difference it made (see Fig. 13). The small saphenous vein 
was constricted with 100 nM noradrenaline in the presence of flurbiprofen (1 pM) and 
the acetylcholine cumulative concentration response curve was constructed. 
Flurbiprofen was unable to assist acetylcholine to relax the vessel any more than 
previously, though it did prevent the vasoconstriction commonly seen with this 
preparation when using high concentrations (> 1 pM) of acetylcholine. Overall the 
magnitude of relaxation was again about equal to one third of the noradrenaline-induced 
constriction.
Still using the small saphenous vein the next aspect to be investigated was the 
difference in the magnitude of relaxation induced by an endothelium-independent as 
opposed to an endothelium-dependent relaxant. The two drugs used in this comparison 
were sodium nitroprusside and acetylcholine respectively. Acetylcholine relaxes the 
vessel via the release of EDRF, while sodium nitroprusside works by direct stimulation 
of the smooth muscle. Figures 14 and 15 show typical traces which were obtained 
from the same preparation on the same experimental day. Both experiments start with 
the vessel being constricted with noradrenaline (100 nM) for 10 minutes followed by a 
cumulative concentration response curve using one of the two"relaxants. Sodium 
nitroprusside (10 nM to 10 fiM) and acetylcholine (100 pM to 1 jiM) were both given 
in 1.0 log unit increments, each concentration being added for 5 minutes. At the end of 
each of the concentration response curves the maximally effective doses of the two 
relaxants were added together to see their combined effect.
In the small saphenous vein sodium nitroprusside was able to completely relax the 
vessel back to baseline (see Fig. 14), even at a concentration as low as 10 nM. The 
velocity of the relaxation was fast with the vessel being relaxed back to baseline within 
approximately 90 seconds after the addition of the drug. A maximally effective dose of 
acetylcholine (1 fiM) added on top of the sodium nitroprusside had no further effect on 
the dimensions of the vessel.
Acetylcholine, on the other hand, was not nearly as effective as a relaxing agent in 
this vessel when compared to sodium nitroprusside. The degree of relaxation was 
more variable than with sodium nitroprusside, though some days it could almost relax 
the vessel back to baseline (see Fig. 15). This trace again shows the transient nature of
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Figure 13
Trace shows the percentage changes in the width for two segments from the rabbit 
small saphenous vein. The vessel was constricted with noradrenaline (100 nM) and 
then relaxed by the cumulative addition of acetylcholine (100 pM to 1 jiM, in 1.0 log 
unit steps). Flubiprofen (1 |iM), a cycloxygenase inhibitor, was present throughout.
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Figure 14
Trace shows the percentage changes in the width for two segments from the rabbit 
small saphenous vein. The vessel was constricted with noradrenaline (100 nM) and 
then relaxed by the cumulative addition of sodium nitroprusside (10 nM to 10 JiM, in 
1.0 log unit steps). Finally acetylcholine (1 jiM ) was added on top of 10 pM sodium 
nitroprusside before wash-out.
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Figure 15
This trace was obtained from the same tissue as the result shown in Fig. 14 and 
again shows the percentage changes in width for two segments from the rabbit small 
saphenous vein. This time the vessel was constricted with noradrenaline (100 nM) and 
then relaxed by the cumulative addition of acetylcholine (100 pM to 1 jiM, in 1.0 log 
unit steps). Finally sodium nitroprusside (10 |iM) was added on top of 1 pM 
acetylcholine before wash-out.
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these relaxations at low concentrations and the more sustained relaxations at higher 
concentrations previously seen in Figure 12. Addition of a maximally effective dose of 
sodium nitroprusside (10 JiM) on top of the acetylcholine was able to completely relax 
the vessel. The speed of relaxation using acetylcholine was again very fast with the 
maximum degree of relaxation achieved by each concentration being reached within a 
few seconds of its addition. So it seems the small saphenous vein is more susceptible 
to relaxation via the endothelium-independent relaxant sodium nitroprusside than it is to 
the endothelium-dependent relaxant acetylcholine.
Role of the endothelium in the rabbit saphenous artery
Exactly the same experiment was performed on the rabbit saphenous artery. Using 
acetylcholine and sodium nitroprusside to relax a noradrenaline-induced constriction 
gave a similar result to that found in the corresponding vein. Sodium nitroprusside in 
most cases was able to totally relax this preparation back to baseline (see Fig. 16), 
though not until the concentration reached 10 (iM. Concentrations less than this value 
caused variable and sometimes unsustained levels of relaxation. Addition of 
acetylcholine (1 jiM) on top of this maximally effective dose of sodium nitroprusside 
caused the vessel to constrict again by about 1 0 %.
Acetylcholine was not only less effective than sodium nitroprusside but was much 
less effective than it had been in the equivalent experiments in the small saphenous vein 
(see Fig. 17). Its ability to relax this vessel was variable, the average maximal degree 
of relaxation being about 33% of the induced constriction. As can be seen from the 
trace the degree of relaxation was not only variable between different preparations but 
was also variable within the same preparation. One of the segments shown has been 
relaxed to a far greater degree than the other. Addition of sodium nitroprusside (10 
JiM) on top of the acetylcholine was capable of bringing the vessel diameter completely 
back to baseline. It must be noted that sodium nitroprusside added at the end of the 
acetylcholine concentration response curve was not always as effective as shown in 
Figure 17.
Effect of intraluminal pressure on endothelial function
Acetylcholine was less effective as a relaxing agent in the artery than in the vein. 
One possible reason for this is the widely different intraluminal pressures which each 
preparation is exposed to with this technique of image analysis (i.e. artery = 1 0 0  
mmHg and vein = 13 mmHg). To investigate this possibility the vein was set up at the 
arterial pressure and vice versa. Setting the vein up at a pressure of 100 mmHg caused
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Trace shows the percentage changes in the width for two segments from the rabbit 
saphenous artery. The vessel was constricted with noradrenaline (100 nM) and then 
relaxed by the cumulative addition of sodium nitroprusside (10 nM to 10 pM, in 1.0 
log unit steps). Finally acetylcholine (1 pM) was added on top of 10 pM sodium 
nitroprusside before wash-out.
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Figure 17
This trace was obtained from the same tissue as the result shown in Fig. 16 and 
again shows the percentage changes in the width for two segments from the rabbit 
saphenous artery. This time the vessel was constricted with noradrenaline (100 nM) 
and then relaxed by the cumulative addition of acetylcholine (100 pM to 1 JiM, in 1.0 
log unit steps). Finally sodium nitroprusside (10 jiM) was added on top of 1 jiM 
acetylcholine before wash-out.
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it be unresponsive to noradrenaline and the preparation was deemed to be non­
functional. The artery, set up at a venous pressure of 13 mmHg, was responsive to 
noradrenaline (100 nM) and produced a large constriction approximately equal to 40%. 
This constriction, which used the same noradrenaline concentration for both pressures, 
was of a similar magnitude in both pressures.
Attempts to relax this constriction were tried using acetylcholine and sodium 
nitroprusside added cumulatively at the same concentrations as used previously. 
Sodium nitroprusside was not as effective as had been seen previously, being able to 
relax the constriction by only about two thirds (see Fig. 18). Addition of 1 pM 
acetylcholine on top of the maximally effective dose of sodium nitroprusside (10 pM) 
relaxed the vessel back to baseline. These essentially artificial conditions, produced by 
exposure to incorrect transmural pressures, also caused the appearance of rhythmic 
activity. This phenomenon will be examined more closely in a later chapter.
Contrary to the results found when the artery was set up at its normal pressure, 
acetylcholine was able to relax the vessel back to baseline (Fig. 19). Acetylcholine only 
showed a clear relaxatory ability once its concentration reached 10 nM. Concentrations 
at and above this value produced dilations which were only partly maintained. The 
addition of sodium nitroprusside (10 pM) on top of the acetylcholine produced a 
sustained dilation, taking the vessel back to baseline. Therefore from the results with 
acetylcholine it seems that the saphenous artery set up under venous conditions is 
behaving more like a vein.
Effect of haemoglobin on endothelial function
Having shown acetylcholine to be able to relax a noradrenaline-induced 
constriction, was it now possible to block this dilation? Haemoglobin is one factor 
which has been shown to prevent the action of acetylcholine by binding the released 
EDRF and therefore preventing it from acting on the vessel walls. In the saphenous 
artery a constriction induced by noradrenaline (100 nM) was relaxed by about 20% by 
the cumulative addition of acetylcholine (10 nM to 1 pM) in 1.0 log unit steps (Fig. 
20).
Repeating the same protocol, this time in the presence of haemoglobin (1 pM), 
totally abolished the relaxation which had been produced previously with acetylcholine 
(Fig. 21). This trace contains results from two segments one of which shows a much 
reduced response to the addition of noradrenaline in the presence of haemoglobin. 
Reasons behind this apparent change in sensitivity are unknown. After addition of 
haemoglobin, the width of the saphenous artery continued to decrease even during the
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Trace shows the percentage changes in the width for three segments from the rabbit 
saphenous artery set up at a venous pressure of 13 mmHg. The vessel was constricted 
with noradrenaline (100 nM) and then relaxed by the cumulative addition of sodium 
nitroprusside (10 nM to 10 JiM, in 1.0 log unit steps). Finally acetylcholine (1 jiM) 
was added on top of 10 pM sodium nitroprusside before wash-out.
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Figure 19
This trace was obtained from the same tissue as the result shown in Fig. 18 and 
again shows the percentage changes in the width for two segments from the rabbit 
saphenous artery set up at a venous pressure of 13 mmHg. This time the vessel was 
constricted with noradrenaline (100 nM) and then relaxed by the cumulative addition of 
acetylcholine (100 pM to 1 |iM, in 1.0 log unit steps). Finally sodium nitroprusside 
(10 p.M) was added on top of 1 fiM acetylcholine before wash-out.
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Figure 20
Trace shows the percentage changes in the width for two segments from the rabbit 
saphenous artery. The vessel was constricted with noradrenaline (100 nM) and then 
relaxed by the cumulative addition of acetylcholine (10 nM to 1 |iM, in 1.0 log unit 
steps) before finally being washed out
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This trace was obtained from the same tissue as the result shown in Fig. 20 and 
again shows the percentage changes in the width for two segments from the rabbit 
saphenous artery. The same protocol was employed here except that haemoglobin (1 
JiM) was added 10 minutes before the addition of acetylcholine to see its effect on the 
relaxation produced by acetylcholine.
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acetylcholine concentration response curve. Only after wash-out did the vessel width 
return to normal.
The corresponding experiment performed on the small saphenous vein gave a less 
pronounced result. Figure 22 shows the constriction produced by noradrenaline (100 
nM) being relaxed by about 50% with the addition of acetylcholine (10 nM to 1 pM). 
Adding haemoglobin (1 pM) with the noradrenaline caused a transient 10% dilation in 
this preparation as well as reducing the degree of relaxation produced by acetylcholine 
to about 32% (Fig. 23). Contrary to the artery, haemoglobin was unable to completely 
block the relaxation. This apparently small effect with haemoglobin in the vein may be 
due to its poor ability to penetrate the vessel wall because of its high molecular weight.
To solve this problem in the vein, haemoglobin was given extraluminally as well as 
intraluminally at the same concentration of 1 pM. Noradrenaline was added from two 
separate reservoirs to make sure that the switching of taps from one reservoir to another 
had no effect on the diameter of the vessel (Fig. 24). Acetylcholine caused a 73% 
relaxation of the noradrenaline-induced constriction, 100 nM being the maximally 
effective dose in this preparation. The presence of haemoglobin both inside and outside 
the vessel (Fig. 25) did increase its ability to block the dilation induced by 
acetylcholine, reducing the degree of relaxation from 73% to 18%. Haemoglobin on 
this occasion had no effect on the constriction produced by noradrenaline.
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Trace shows the percentage changes in the width for two segments from the rabbit 
small saphenous vein. The vessel was constricted with noradrenaline (100 nM) and 
then relaxed by the cumulative addition of acetylcholine (10 nM to 1 jiM, in 1.0 log unit 
steps) before finally being washed out
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This trace was obtained from the same tissue as the result shown in Fig. 22 and 
again shows the percentage changes in the width for two segments from the rabbit 
small saphenous vein. The same protocol was employed here except that haemoglobin 
(1 pM) was added 10 minutes before the addition of acetylcholine to see its effect on 
the relaxation produced by acetylcholine.
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Trace shows the percentage changes in the width for two segments from the rabbit 
small saphenous vein. The vessel was constricted with noradrenaline (100 nM) and 
then relaxed by the cumulative addition of acetylcholine (10 nM to 1 fiM, in 1.0 log unit 
steps) before finally being washed ou t
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This trace was obtained from the same tissue as the result shown in Fig. 24 and 
again shows the percentage changes in the width for two segments from the rabbit 
small saphenous vein. The same protocol was employed here except that haemoglobin 
(1 jiM) was added both intraluminally and extraluminally 10 minutes before the 
addition of acetylcholine to see its effect on the relaxation produced by acetylcholine.
81
DISCUSSION
The vasodilation induced by acetylcholine, via release of EDRF, has been further 
confirmed using image analysis. This technique, which is essentially an isotonic 
recording, has enabled the study of the endothelium from a new angle. Although 
plenty of results have been obtained using isometric recording methods (e.g. cut-rings) 
very little was known about the dimensional changes caused by EDRF when under 
more physiological conditions. Image analysis has allowed vessels to be set-up with 
limited damage to the fragile endothelium and with a transmural pressure more closely 
related to that found in vivo.
Role of endothelium in rabbit small saphenous vein
The starting point in my investigation, contrary to most studies on the endothelium, 
began with looking at the venous as opposed to the arterial side of the vasculature. 
Early workers in this field have tended to concentrate their efforts in arteries where 
some initial success had been achieved in the rabbit thoracic aorta (Furchgott et al., 
1981; Furchgott, 1981; Furchgott & Zawadzki, 1980). By firstly inducing tone with 
noradrenaline (100 nM, EC^o value) the influence of the endothelium was assessed 
with concentration response curves to acetylcholine. Initially, using image analysis, the 
rabbit small saphenous vein was the vessel studied. This is a vessel where very little is 
known about endothelial function.
The first thing which was noticed in a limited number of the traces was a variability 
in the response to noradrenaline (Fig. 12), something which has been commented upon 
in the last chapter. Extreme cases showed adjacent segments to be varying by as much 
as two-fold in their respective magnitudes. One possible explanation may be 
differences in the density of innervation along the length of a vessel. Pascual et al. 
(1989), using rabbit aortic rings, also recorded wide variations in response to 
noradrenaline. However, this was only seen when the endothelium was intact, once 
the endothelium had been removed then the variations disappeared. They concluded 
that the variations were due to EDRF, though since (X2 -adrenoceptors are present on the 
endothelium as well as on the smooth muscle it seems likely that receptor density may 
also play some part in this variability.
Acetylcholine at concentrations as low as 100 pM was able to cause relaxations in 
this preparation. At or below 1 nM these relaxations tended to be only transient in 
nature (Fig. 12). This transient behaviour to the addition of acetylcholine was noted in 
the canine saphenous vein by De May & Vanhoutte (1982) at all concentrations tested.
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With image analysis this was not the case. Acetylcholine concentrations above 1 nM 
gave constrictions which were at least partly maintained. The existence of transient 
relaxations could be related to conflicting effects by acetylcholine at the endothelium, 
possibly by the release of constrictor substances, though many other factors have been 
suggested and there is no generally accepted theory to explain it.
All responses to acetylcholine, both transient and maintained, were characterised by 
an initial swift dilation which reached a peak within a minute of its addition. This speed 
of response was greater than the constrictor responses noted with agonists such as 
noradrenaline and may be due to the different receptors responsible for each response. 
Agonists mediate their constriction via a-adrenoceptors on the smooth muscle, while 
acetylcholine works via muscarinic receptors present on the endothelium.
The transient nature of responses to acetylcholine against an agonist-induced 
constriction have also been seen in the small saphenous vein (Fig. 15) and the lateral 
saphenous vein (McGrath et a l , 1990b) when the endothelium is intact and the 
acetylcholine concentration has been high (>1 pM). In fact in many instances 
acetylcholine added at these concentrations have caused a constriction of the vessel. 
This response was though to be due to cycloxygenase activation, via the release of 
prostaglandins since addition of a cycloxygenase inhibitor called flurbiprofen increased 
the maximum relaxation produced by acetylcholine and prevented the constrictions in 
the lateral saphenous vein (McGrath et al., 1990b). A repeat of this experiment using 
image analysis and the small saphenous vein produced a less clear-cut result (Fig. 15). 
Flurbiprofen was able to block the acetylcholine-induced constrictions but it did not 
increase the maximum relaxation when compared to the control.
It was important when assessing the action of drugs such as flurbiprofen to 
compare responses with a control found on that same day, since wide variations in the 
potency of acetylcholine were seen in the small saphenous vein. The degree of 
relaxation induced by acetylcholine in a vessel, constricted with noradrenaline, ranged 
from about 33-100%. It is worth noting that as more experiments were done this 
degree of relaxation steadily increased. This suggests that practice in the dissection 
process had enabled the preparation to be set up with a more intact endothelium. An 
overall average for percentage relaxation by acetylcholine gave a value of over 60% 
which is something of an intermediate value when compared to results found in other 
isolated venous preparations.
Working with activated canine veins De May & Vanhoutte (1982) stated that the 
saphenous was one of the few veins to show any relaxation to acetylcholine, the 
maximum relaxation being only about 30%. Ignarro et al. (1987b) also showed poor 
responses to acetylcholine in the bovine intrapulmonary vein. In contrast McGrath et
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al. (1990b), using the rabbit saphenous vein, found acetylcholine could completely 
relax an agonist-induced constriction. So what is the reason for this massive variation 
in the potency of acetylcholine? There are probably many factors contributing to this 
variation, including interspecies differences as well as anatomical differences within the 
same species. Another obvious factor is the experimental method used, with invasive 
techniques such as cut-rings and helical strips increasing the possibility of endothelial 
damage during the setting up process. These techniques often used artificial values for 
tension and do not subject the vessel to a physiological transmural pressure during 
experimentation, unlike the image analysis method. The extent of pre-existing tone is 
also a factor which has been shown to have an effect on the potency of acetylcholine in 
the rabbit saphenous vein (McGrath et al., 1990b), highlighting once more the 
importance of the transmural pressure in endothelium-dependent responses.
Role of endothelium in the rabbit saphenous artery
As explained earlier the arterial side of the vasculature had been shown to be greatly 
influenced by the endothelium, via the release of EDRF, in a number of different 
isolated preparations (Furchgott et a l, 1981; Furchgott, 1981; Furchgott & Zawadzki, 
1980; Ignarro et al., 1987b; Rubanyi & Vanhoutte, 1988). However, results from this 
study and by McGrath et al. (1990b) contradict this theory with respect to the rabbit 
saphenous artery. Both studies found that addition of acetylcholine to relax an agonist- 
induced constriction was less effective than it had been when using the corresponding 
vein. Possible reasons to account for the totally different responses seen with this 
preparation are the same as listed for the vein. Though, since McGrath et al. (1990b) 
were using cut-rings and image analysis uses a perfused preparation, it appears that the 
contrasting results seen in both the artery and vein cannot be attributed to differences in 
the methodology used.
Reasons to account for the different potency of response between the vein and the 
artery must also be considered. Bassenge et al. (1987) suggested that it was due to the 
greater media thickness of the arterial as compared to the venous preparation. This 
would hinder the diffusion of EDRF through the blood vessel wall thereby rendering 
the contractile responses of the artery more resistent to the relaxant. Although 
discounted by McGrath et al. (1990b) this is one of many possibilities which cannot be 
ruled out from the results obtained with image analysis. These results, unlike the cut- 
ring results, exposed a difference in the potencies of the endothelium-independent 
relaxant (sodium nitroprusside) as compared to the endothelium-dependent relaxant 
(acetylcholine) in the saphenous artery. Since the potency of sodium nitroprusside is
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greater it may be that the diffusion of EDRF is in fact hindered by the thicker media of 
the artery.
Another possibility is that the high transmural pressure exerted upon the artery is 
the dominant factor responsible for acetylcholine’s poor potency. Evidence for this 
came from the fact that setting the artery up at a venous pressure (13 mmHg) caused it 
to behave more like a vein with respect to the potency of acetylcholine (see Fig. 19). 
This was only a one-off experiment and therefore further investigation would be 
necessary before any definite conclusions could be drawn.
The difference may also be related to the fact that noradrenaline was the contractile 
agent used in both preparations. Noradrenaline is a substance which contracts the 
vessel by depolarising the smooth muscle and opening voltage-operated calcium 
channels. These voltage-operated channels have been shown to be more resistent to the 
nitrovasodilators (see Ignarro & Kadowitz, 1985) and to endothelium-dependent 
relaxants (Furchgott, 1983) than the receptor-operated channels which noradrenaline 
also uses. Thus the insensitivity of noradrenaline to acetylcholine in the artery may be 
due to the greater utilisation of voltage-operated calcium channels, while the responses 
in the vein may depend more on the receptor-operated channels. Other results by 
Schumann & Lues (1983) and McGrath & Wilson (unpublished) also lend support to 
the theory that the coupling process utilised by the contractile agents determines the 
effectiveness of the endothelium-dependent relaxants.
Acetylcholine v ’s Sodium nitroprusside in the rabbit small saphenous vein and the
saphenous artery.
Acetylcholine has been shown, on occasion, to be able to almost completely relax 
the small saphenous vein back to baseline when exposed to a sub-maximal 
noradrenaline concentration (EC6o). When its average effectiveness is compared 
directly, using a single preparation, to that of sodium nitroprusside (an endothelium- 
independent relaxant) then acetylcholine was shown to be less effective (see Figs. 14 & 
15). Exactly the same result was seen using the saphenous artery, as well as a number 
of other isolated preparations from the rabbit (e.g. rabbit aorta, Collins et al., 1988). 
Collins et al. found sodium nitroprusside capable of completely relaxing the vessel, 
while acetylcholine could only relax it by about half when exposed to noradrenaline. 
No explanation of this difference in potency was offered by the authors.
With image analysis the residual tone remaining in both vessels after addition of a 
maximally effective dose of acetylcholine could be eliminated by the addition of the 
maximally effective dose of sodium nitroprusside. This suggests that any inadequacy
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by acetylcholine to relax the vessels was not due to defects in the contractile process 
itself, since both of these relaxants have a common pathway (activation of soluble 
guanylate cyclase; Rapoport & Murad, 1983). What it does suggest is that the 
difference in potency is due to some factor connected with the endothelium. The exact 
nature of this factor is uncertain, but may be as simple as damage to the endothelium 
caused during dissection or as complicated as the simultaneous release of constrictor 
substances by the endothelium. Transmural pressure, which was one factor suggested 
to be important in the potency of acetylcholine, may also have some effect on the degree 
of relaxation produced by sodium nitroprusside. A preliminary experiment, where the 
pressure in the artery was decreased, caused sodium nitroprusside to be less effective 
than when set up at a normal arterial pressure. Further experiments are required before 
pressure can be confidently quoted as one of the factors important in the functioning 
both of endothelium-dependent and endothelium-independent relaxants.
Effect of haemoglobin in the rabbit small saphenous vein and the saphenous artery
Haemoglobin has been confirmed as a substance which can mimic the mechanical 
removal of the endothelium (Martin et al., 1986b), and removal of the endothelium has 
been shown to augment a-adrenoceptor-mediated contractions in endothelium-intact 
preparations (Lues & Schumann, 1984; Godfraind et al., 1985). Both of these results 
taken together have suggested the presence of a basal release of EDRF from arterial and 
venous preparations. However, there has been some conflicting evidence on this 
subject with many preparations not showing any increase in either their potency 
(Oriowo et al., 1987) or their sensitivity (Ignarro et al., 1987a) with the agonists tested. 
Using image analysis there was seen to be no change in either of these two parameters 
when noradrenaline was the agonist. Haemoglobin given on top of a sub-maximal 
noradrenaline concentration had no additional effect on the constriction produced by the 
agonist in either the vein or the artery.
This result may be partly explained by the fact that full agonists, such as 
noradrenaline, are not effected to the same degree by basal EDRF release as partial 
agonists (Martin et al., 1986b). The lack of effect may also be due to the vessels used, 
though McGrath et al. (1990b) did produce evidence showing the basal release of 
EDRF using roughly the same preparations (the vein was taken from a slightly higher 
position).
Although haemoglobin did not affect the potency or sensitivity of noradrenaline in 
the vessels used it was able to limit or abolish its subsequent endothelium-mediated 
relaxation, induced by acetylcholine. This is presumably via the same mechanism as 
described by Martin et al. (1985, 1986a), i.e. haemoglobin inhibits EDRF-induced
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endothelium-dependent relaxations by binding to EDRF and therefore preventing it 
acting on the smooth muscle. They confirmed this by the fact that the EDRF-mediated 
increases in the cGMP levels in the smooth muscle, which leads to relaxation of the 
vessel, is decreased by haemoglobin. The ability of haemoglobin to inhibit the 
relaxation in both the small saphenous vein and the saphenous artery suggests that 
relaxations are via a common EDRF, presumably nitric oxide (Palmer et a l , 1987).
Like McGrath et al. (1990b) results presented here show that haemoglobin was able 
to totally abolish the acetylcholine-induced dilation in the saphenous artery (Figs. 
20 & 21). The relatively small constriction produced in this preparation was if anything 
increased by the addition of haemoglobin, with no signs of relaxation present. Looked 
at on its own this result would suggest that haemoglobin is not only blocking the 
release of EDRF by acetylcholine but also the basal release described earlier to be 
present in some isolated vessels. However, if this were so then the trace would be 
expected to show an increased response to noradrenaline, which as stated earlier it did 
not. Therefore haemoglobin perfused through the artery only seems to effect the EDRF 
which has been released by the addition of acetylcholine.
The same result was found in the small saphenous vein, though in this vessel 
haemoglobin’s potency was not sufficient to abolish the response, only reduce it (Figs. 
22 & 23). This reduction in the response was surprising small when haemoglobin was 
given only intraluminally. Pascual et al. (1989), using the aorta, had stated that 
haemoglobin was only effective when given via this route and was without effect when 
given via the adventitia (extraluminally). This was not the result with image analysis 
where addition both intra- and extraluminally did produce a more pronounced inhibition 
them when given intraluminally only (Figs. 24 & 25). The poor response when given 
intraluminally was regarded as being due to poor diffusion rates through the tissue, 
though this was not seen in the thicker walled artery. Overall size of response may be 
more important since the acetylcholine-induced relaxation was much larger in the vein 
than in the corresponding artery.
The much improved effectiveness of haemoglobin when given extraluminally as 
well as intraluminally is surprising for a number of reasons apart from the one 
mentioned above. Firstly it was thought that those layers of the smooth muscle which 
lie closest to the endothelium are the ones effected most by EDRF (Pascual et a l, 
1989). Secondly EDRF is thought to be nitric oxide which has an short half life 
(Palmer et al., 1987) therefore making it unlikely that it will still be active by the time it 
diffuses through to the outer smooth muscle layers. Finally, intraluminally added 
acetylcholine has been shown to be much more effective as a relaxant agent than when 
applied extraluminally in a number of preparations (Pascual et a l, 1984; Vedernikov et
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al., 1987). All this evidence supports the view that EDRF’s influence does not play a 
major role in the outermost smooth muscle layers. On the other hand results with 
image analysis suggest that EDRF may exert its effect throughout the entire wall of the 
vessel.
8 8
CHAPTER 3
RHYTHMIC ACTIVITY IN THE RAT 
THORACIC AORTA & PORTAL VEIN AND 
THE RABBIT SAPHENOUS ARTERY
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INTRODUCTION
Rhythmic activity
Scientists have been aware of the existence of rhythmic activity in blood vessels for 
some time, though detailed in vitro work did not start until the mid-sixties. There have 
been two broad classes of blood vessel studied, one which shows spontaneous 
rhythmic activity and the other which only shows rhythmic activity when they have 
been activated by some mechanical or chemical factor. However, some results have 
made it difficult to categorize certain vessels into one of these classes with any degree 
of confidence.
Johansson & Bohr (1966) were two of the early workers in this field, initially 
looking at vessels taken from the hindpaws of dogs. They restricted their work to the 
arterial side of the vasculature with the saphenous artery being among the preparations 
used. Each of the vessels were cut into helical strips and attached to a transducer to 
exert a suitable tension on the preparation. Addition of physiological salt solution to 
these vessels caused them to exhibit rhythmic activity which displayed a variable 
frequency. This spontaneous rhythmic activity could be abolished for 20-40 minutes 
by the application of freshly aerated physiological salt solution, suggesting the activity7 
to be caused by changing conditions in the salt solution (e.g. loss of CO2  or O2 , pH 
changes, or metabolite accumulation). Fasehun et al. (1987a), studying the effect of 
oxygen on spontaneous rhythmic activity in the rat portal vein, stated that the PO2  did 
not have an influence on this activity though it did effect the degree of constriction 
elicited by noradrenaline.
In Johansson & Bohr’s experiments (1966) addition of vasoactive agents, like 
noradrenaline, resulted in a two phase response. The first phase consisted of a tonic 
rise in tension, which was accompanied by the appearance of phasic contractions which 
were superimposed on this tonic contraction. In the case of noradrenaline a 
concentration of about 100 nM was optimal for showing the rhythmic activity at its 
most pronounced. Concentrations substantially above or below this value caused the 
abolition of these phasic waves of contraction.
One year later Johansson et al. (1967) had switched their attention to the study of 
the rat portal vein, a vessel known to exhibit spontaneous rhythmic activity. The 
addition of sub-maximal concentrations of noradrenaline (30 nM) was shown to 
increase the tone and also to increase the frequency of this rhythmic activity. During 
the first minute of stimulation, with noradrenaline, the rhythmic activity seemed to be 
without any sort of constant frequency, after which time the vessel did settle down into
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a regular pattern of phasic activity. This was not the case when a maximal 
noradrenaline concentration of 30 p.M was used in this vessel. In this case 
noradrenaline caused an increase in tension but at the same time abolishing the rhythmic 
activity. The authors concluded that this maximal dose of noradrenaline had induced 
the smooth muscle cells into tetanus, therefore causing the appearance of a smooth 
maintained contraction. Fasehun et al. (1986) also found that at low noradrenaline 
concentrations the rat portal vein exhibited an increase in rhythmic activity. Increasing 
the noradrenaline concentration towards a maximal dose again induced a fused 
contraction. Using ai-agonists, like phenylephrine, produced the same response. 
However, ot2 -agonists, like UK-14304, only produced an increase in the phasic 
activity without producing a contraction.
The factors responsible for rhythmic activity have been analysed in a number of 
different preparations by firstly inducing this activity with agonists and then trying to 
abolish it with various chemical factors. Myers et al. (1985) have done a detailed study 
of the factors responsible for this rhythmic activity in hypertensive stroke-prone rats. 
They obtained rat tail artery’s from both Kyoto-Wistar normotensive rats and the 
spontaneously hypertensive stroke-prone rats. Activation of these vessels with 
noradrenaline caused them to constrict. In the hypertensive rats rhythmic activity 
appeared superimposed on top of this induced tone, while in the normotensive rats 
there was no sign of rhythmic activity. Examination of this activity showed it to be 
present only when exposed to noradrenaline concentrations above 2 nM, with its 
frequency peaking at about 300 nM. Intervention with various chemical factors to 
characterize the mechanism behind this phasic activity showed it to be sensitive to three 
things, blocking of the electrogenic sodium pump, depolarisation of the cell membrane 
and inhibiting the entry of calcium into the cell. Factors which alter the noradrenaline 
availability (e.g. cocaine) or cause endothelium-independent vasodilation (sodium 
nitroprusside) in this preparation had no effect on the phasic activity.
It seems clear though that the mechanisms responsible for rhythmic activity in the 
various preparations which exhibit it are not the same. For instance, in rat portal vein it 
has been reported that moderate increases in the extracellular potassium concentration 
augments phasic activity (Shepherd & Vanhoutte, 1975). However, this was not the 
case with the tail artery from hypertensive rats (Myers et al., 1985) or the hamster aorta 
(Jackson, 1988). Pharmacological studies with potassium channel blockers has led 
Lamb et al. (1985) to propose that calcium-dependent potassium channels are involved 
in the rhythmic contractions observed in tail arteries of hypertensive rats. This theory is 
supported by the finding that high potassium solutions, removal of extracellular calcium 
and calcium channel blockers all inhibit rhythmic activity in the hamster aorta (Jackson,
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1988). However, the hamster aorta was not effected by nonspecific potassium channel 
blockers, unlike the rat tail artery (Lamb et al., 1985; Myers eta l., 1985).
The rhythmic activity seen upon activation in the hamster aorta (Jackson, 1988) has 
been suggested to be dependent upon an intact endothelium, since removal of the 
endothelium abolishes this activity. Further weight to this theory is provided by the 
fact that addition of haemoglobin, which binds EDRF making it ineffective (Martin et 
al., 1985), markedly reduces this activity. One further piece of supportive evidence is 
that both release of EDRF (Long & Stone, 1985) and rhythmic activity are calcium 
dependent. However, this endothelium-dependent theory is one which has been ruled 
out in the past (Stein & Driska, 1984; Lamb et al., 1985; Myers et al., 1985). What 
can generally be agreed though is that rhythmicity is not due to phasic release of 
transmitter from the nerve terminals, since the use of various adrenergic/cholinergic 
antagonists and prostaglandin inhibitors have had no effect on rhythmic activity.
Aims of the study
To look at rhythmicity both in spontaneously active vessels, like the rat portal vein, 
and agonist activated vessels, like the rabbit thoracic aorta and saphenous artery. Image 
analysis should give a new angle to the study of rhythmicity present in isolated blood 
vessels, allowing the pattern of activity to be detected and quantified. By using high 
frame rates (one per second) it should be possible to see whether the rhythmic activity 
originates from a pacemaker region, is propagated in all directions and what speed this 
propagation proceeds along the vessel. Frequency and amplitude of this rhythmic 
activity are also parameters which can easily be measured using image analysis.
Stimulation for those vessels which are not spontaneously active involved the 
agonist noradrenaline, which would be relaxed with vasodilators (sodium 
nitroprusside) therefore showing what conditions are optimal for the appearance of 
rhythmic activity. A range of concentrations for each of the two substances would be 
used. The influence of the transmural pressure would also be investigated by varying 
the height of the reservoirs which supply the vessel. Does rhythmic activity only 
appear in some tissues when they are exposed to effectively unphysiological 
conditions?
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MATERIALS AND METHODS
Rhythmic activity
The phenomenon of rhythmic activity was studied firstly in rat portal vein. 
Noradrenaline was given as a cumulative concentration response curve (0.1 nM to 10 
JiM) in 1.0 log unit increments to constrict the tissue and see what effect this had on the 
properties of the vessel. After being washed-out this preparation still showed rhythmic 
activity which was analysed more closely by increasing the frame speed to 1 per 
second. The second preparation to be studied, the rat thoracic aorta, was also exposed 
to a noradrenaline cumulative concentration response curve (0.1 nM to 10 |iM). The 
noradrenaline ECgo value, found to be 0.1 pM, was combined with the maximally 
effective dose of acetylcholine (1 pM) for 5 minutes to see the effect it had on the 
rhythmic activity. Phenylephrine, the ai-agonist, was also used with this preparation 
in the form of a cumulative concentration response curve (0.1 nM to 10 JiM).
The rabbit saphenous artery was the final vessel to be analysed for the presence of 
rhythmic activity. Initially the pressure applied was the normal one of 100 mmHg, 
with the vessel being firstly exposed to a 20 minute period of noradrenaline (1 nM). 
This was washed out and then given again for a further 10 minutes on its own and then 
for 15 minutes in combination with firstly 1 nM sodium nitroprusside and then 100 nM 
sodium nitroprusside. After a further wash-out the entire procedure was repeated, this 
time using 100 nM instead of 1 nM noradrenaline.
Further experiments with this preparation were conducted with the artery under a 
venous pressure of 13 mmHg. Again the preparation was exposed to noradrenaline 
(100 nM) and then relaxed with sodium nitroprusside. This time though each drug 
addition period lasted 1 0  minutes and the sodium nitroprusside was added cumulatively 
in 1.0 log unit increments with concentrations ranging from 10-1000 nM. Once 
appropriate conditions had been determined to cause rhythmic activity in the vessel then 
the frame speed was increased to one per second to take a closer look at the properties 
of this rhythmic activity. At the end of one of the experimental days during which 
rhythmic activity had been seen the pressure was stepped up to a normal arterial value 
of 100 mmHg to see if this activity could be maintained.
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RESULTS
Rhythmic activity has been shown extensively using isometric techniques in a 
variety of different preparations such as the canine saphenous artery (Johansson & 
Bohr, 1966) and the rat portal vein (Fasehun et al., 1986). These preparations have 
been set up under essentially unphysiological conditions of longitudinal tension and 
transmural pressure. With image analysis these parameters can be set at levels closer to 
their true physiological value, with the subsequent measurements being isotonic instead 
of isometric. By mimicking the in vivo environment this technique will show whether 
the presence of rhythmic activity seen in vitro is a real phenomenon in the intact animal 
or whether it is a artefact of the dissection process. All traces shown represent results 
obtained from capturing frames at a faster rate than that used in previously described 
experiments, i.e. 1 per second as opposed to 1 per 3 seconds. This increased frame 
rate was introduced to record the anticipated faster responses involved in rhythmic 
activity.
First vessel to be analysed was the rat portal vein which has been shown previously 
to exhibit spontaneous rhythmic activity. A noradrenaline cumulative concentration 
response curve (100 pM to 10 |iM) in 1.0 log unit steps was constructed using this 
tissue (Fig. 26), the maximum constriction produced by noradrenaline being small at 
only 8 %. The trace shows that even in the presence of Krebs alone, during the control 
period and after washing out noradrenaline, this vessel exhibits rhythmic activity. The 
frequency of this spontaneous activity was calculated to be 4/minute both in the 
presence of Krebs alone and for noradrenaline concentrations up to 10 nM. When the 
noradrenaline concentration reached 100 nM then the frequency was reduced to 
2/minute. Any further increases in the noradrenaline dose resulted in the abolition of 
this rhythmic activity which could be re-introduced by washing out the vessel with 
Krebs.
Amplitude of the rhythmic activity, in contrast to the frequency, remained fairly 
constant at a value of 2-3%. Figure 26 shows the result from only one segment since 
rat portal vein contains many side-branches thereby necessitating the use of a small 
length of this blood vessel. This limitation prevented the vessel being used further as it 
was found to be too difficult to obtain a branch-free segment of sufficient length for 
cannulation.
Next preparation studied was the rat thoracic aorta which did not exhibit 
spontaneously rhythmic activity. Addition of noradrenaline (<xi/oc2 -agonist) to constrict 
the tissue and then acetylcholine to relax it failed to induce rhythmicity. Switching to
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Figure 26
Trace shows the percentage changes in the width for one segment from the rat 
portal vein. The vessel was constricted with noradrenaline (100 pM to 10 JiM, in 1.0 
log unit steps) before the final 5 minute wash-out period.
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phenylephrine, an ai-agonist, also failed to produce the desired effect. This led to the 
abandonment of the use of this preparation in the study of rhythmic activity.
Final preparation used, was the rabbit saphenous artery, a vessel where rhythmic 
activity had been seen previously using image analysis (see Fig. 18). This trace shows 
the response of a saphenous artery set up at a venous pressure of 13 mmHg. Rhythmic 
activity was present only in this trace when the noradrenaline-induced constriction was 
relaxed with 10 JiM sodium nitroprusside.
Initial investigation of rhythmic activity in this vessel involved exposing it to a 
normal arterial pressure of 100 mmHg. Various concentrations of noradrenaline (1-100 
nM) with and without sodium nitroprusside (1-100 nM) failed to exhibit rhythmic 
activity. This prompted the reduction of the pressure down to 13 mmHg, a value 
previously shown to induce the appearance of rhythmic activity when activated. Each 
experimental day began by adding noradrenaline (100 nM) firstly on its own and then 
with sodium nitroprusside (10 nM to 10 jiM, in 1.0 log unit steps) at a frame speed of 
1 per 3 seconds. Rhythmic activity was indeed seen both with noradrenaline and with 
the lower sodium nitroprusside concentrations (<100 nM). At this point the frame 
speed was stepped up to 1 per second to take a closer look at this rhythmicity.
Figure 27 shows one such trace where noradrenaline has been added for 5 minutes 
after the control period. A large constriction equal to approximately 40% has been 
induced by noradrenaline. Immediately upon reaching this much reduced diameter 
rhythmic activity is seen to be induced in all four of the segments of the artery. The 
peaks for each individual segment were seen to arrive in a specific order, the segment 
closest to the out-going cannula being the first to peak and the segment closest to the in­
going cannula being the last to peak. This result suggested that the rhythmic activity 
was in the form of a propagated wave. By measuring the distance between the first and 
last peak it was possible to calculate the average speed of this propagation, which was 
found to be 1.5 mm/second. Frequency and amplitude of the rhythmic activity were 
also calculated. The frequency was equal to 4.2/minute, while the amplitude was found 
to be 3 .5 % initially though later on this value did decrease down to less than 1 %.
Values for frequency and amplitude did show some variation between different 
experimental days in this preparation, though in general this variation was not of a large 
magnitude. The range for frequency was 4-7/minute and for amplitude was 3.5-8%. 
Only one saphenous artery displayed any definite signs of propagation suggesting its 
true existence to be questionable. Sodium nitroprusside, added along with 
noradrenaline, did not alter the characteristics of the rhythmic activity to any significant 
degree.
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Figure 27
Trace shows the percentage changes in the width for four segments from the rabbit 
saphenous artery which was set up under a venous pressure of 13 mmHg. The vessel 
was constricted with noradrenaline (100 nM) for 5 minutes which caused the 
introduction of rhythmic activity in all the segments.
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Figure 28
Trace shows the percentage changes in the width for two segments from the rabbit 
saphenous artery which was set up under a venous pressure of 13 mmHg. The vessel 
was constricted with noradrenaline (100 nM) for 5 minutes which caused the 
introduction of rhythmic activity in both the segments.
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Having been able to consistently obtain rhythmic activity in the saphenous artery 
under an artificial (venous) pressure of 13 mmHg was it now possible to obtain it at an 
arterial pressure? Figure 28 shows a typical trace of rhythmic activity seen with the 
saphenous artery under a venous pressure. On the same day using the same 
preparation the pressure was then increased to an arterial one of 100 mmHg. The result 
was that the width of the vessel increased by about 2 1 % with the pressure change and 
the magnitude of the elicited constriction was similar to that produced at the venous 
pressure. However, the big difference when the pressure was increased was that the 
rhythmic activity disappeared (Fig. 29).
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Figure 29
This trace was obtained from the same tissue as the result shown in Fig. 28 and 
again shows the percentage changes in the width for two segments from the rabbit 
saphenous artery. The same protocol was employed here except that the vessel was set 
up under an arterial pressure of 100 mmHg to see how this effected the previously seen 
rhythmic activity in this vessel.
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DISCUSSION
Previous studies looking at rhythmic activity in isolated vessels have tended to 
concentrate, quite understandably, on the mechanisms which underlie this 
phenomenon. These studies have shown some consistencies between different tissues 
and also some subtle and profound variations in the mechanisms behind this activity. 
Common factors seem to be the need for extracellular calcium (Fasehun et a i, 1987b) 
and the possession of highly permeable membranes (Myers et al., 1985; Jones & 
Miller, 1978), while the need for a functional endothelium is still under some debate 
(see Jackson, 1988). Further evidence to reinforce or contradict previous theories on 
these myogenic or endothelium-mediated mechanisms was, however, not the aim of 
this study.
What this study wanted to do was not find the mechanisms behind the rhythmic 
activity present in the vessels examined but to look at the overall dimensional changes 
caused by this activity. Much of the published evidence, showing the presence of 
rhythmic activity, has been obtained using fairly invasive in vitro techniques (e.g. 
helical strips). With the less invasive image analysis method rhythmic activity has been 
seen in an extended, relatively intact, piece of blood vessel. Two blood vessels which 
anatomically are from very different regions, the rat portal vein and the rabbit 
saphenous artery, were the only two vessels to show rhythmic activity.
The rat thoracic aorta, a vessel which had been described earlier to possess 
rhythmic activity when activated (Biamino & Kruckenberg, 1969), was also analysed 
but showed no signs of rhythmicity with this technique. This apparently negative result 
may be due to the difficulty encountered in setting up this preparation. The thoracic 
aorta has a series of branches along its length making it difficult to obtain an adequate 
branch-free segment for cannulation. Because of this problem it may be that this vessel 
was subjected to more damage than the other vessels analysed. If this caused 
disruption of the endothelium and if, like the hamster thoracic aorta, the endothelium is 
thought to be essential for the appearance of rhythmic activity (Jackson, 1988) then this 
might be one possible reason for the lack of rhythmicity seen in the rat thoracic aorta.
Like the rat thoracic aorta the portal vein is also a vessel rich in side branches which 
again made it very difficult to study the properties of the rhythmic activity along a an 
adequate length of the vessel. This problem prevented the vessel being analysed in 
detail, though enough data was collected to be able to draw some conclusions. In the 
rat portal vein rhythmic activity was seen both spontaneously and when activated with 
the non-specific a-adrenoceptor agonist noradrenaline (Fig. 26). Both the magnitude 
and frequency of this activity when activated with noradrenaline were dependent on its
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concentration. The higher concentrations (>100 nM) abolished the rhythmic activity, 
though as suggested by Fasehun et al. (1986) this abolition may be regarded as an 
unphysiological artefact. Results from experiments which have measured the peak 
noradrenaline concentration in vivo have indicated that these high concentrations are 
never reached, not even during severe exercise.
With the lower noradrenaline concentrations differences were seen in the frequency, 
but not the magnitude, of the activity. In this preparation the appearance of 
spontaneous rhythmic contractions has been attributed to spontaneous depolarisations 
(pacemaker potentials) and action potentials. Therefore the decrease in frequency seen 
as the noradrenaline dose was increased must be caused by some factor which either 
attenuates the rate of depolarisation or causes an increase in the time interval between 
the individual action potential bursts which cause the smooth muscle to contract. Since 
this activity can be blocked with calcium channel blockers and augmented with 
moderate increases in the extracellular potassium concentration it is assumed that these 
two ions play a critical role in the pattern of rhythmic activity. What exactly this role is 
cannot be pin-pointed at present.
The only vessel which was studied in detail was the rabbit saphenous artery, the 
only preparation where an adequate branch-free segment could be dissected out. This 
had been a vessel where the appearance of rhythmic activity was discovered accidently 
by setting the vessel up at an artificial transmural pressure of 13 mmHg (a venous 
pressure). No spontaneous rhythmic activity was recorded with this tissue, only when 
the vessel was activated with noradrenaline was rhythmic activity seen. This result 
contradicts a much earlier study on the same preparation by Johansson & Bohr (1966) 
who did see spontaneous rhythmic activity, though they had used helical strips.
What both techniques did reveal in this tissue was the inconsistent presence of a 
propagated wave. Figure 27 shows 4 segments which are all displaying rhythmic 
activity, with each segment peaking in a specific order relative to one another. This 
implies that the individual smooth muscle cells must be able to communicate with each 
other in this particular preparation. It also implies that there may be a pacemaker region 
from where this propagation spreads along the vessel. Speed of propagation at 1.5 
mm/second is surprisingly slow, being substantially less than other smooth muscle 
preparations such as gut where propagation rates are as much as 40 times faster. Later 
experiments (Fig. 28) tended to cast doubts on this propagation theory, showing no 
real evidence for the presence of a propagated wave, with the individual segments 
showing no degree of synchronization.
Unlike the portal vein, no variation in frequency was seen within the same 
saphenous artery preparation irrespective of the drugs used, i.e. noradrenaline and
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sodium nitroprusside, though there were variations between different preparations. 
These variations were, however, small when compared to the overall constrictions 
induced by the introduction of noradrenaline. Two points became obvious from using 
the two drugs mentioned above, firstly that for rhythmic activity to be present in this 
vessel it must be under some degree of tone, and secondly, that a substance which 
eliminates this tone (i.e. sodium nitroprusside) will also abolish the rhythmic activity if 
its concentration is high enough. The fact that the magnitude of this rhythmic activity 
tended to decrease within the space of a few minutes after its initiation seems to suggest 
that the mechanisms responsible for it are not sustainable. This is in contrast to the 
trace obtained from the rat portal vein. Why the magnitude is not maintained in the 
saphenous artery is not clear, though it does suggest that rhythmic activity may only be 
present in this tissue when there is a changing environment caused in this case by the 
introduction of noradrenaline.
One factor which was critical for the appearance of rhythmic activity in the 
saphenous artery was an artificially low transmural pressure (Figs. 28 & 29). This 
could be the explanation why rhythmic activity is so readily seen in cut-ring 
preparations where the vessel is also under artificial and essentially unphysiological 
conditions of tension and pressure. It has been noted previously by Johansson & Bohr 
(1966) that alterations in the tension, by passive stretch, can influence the appearance of 
the rhythmic activity. In actual fact they found that increasing the tension caused the 
frequency to also increase. It has been suggested in the rat portal vein that increases in 
the frequency can cause a fusion of this rhythmicity to form a maintained contraction 
(Johansson et al., 1967). Therefore the lack of rhythmicity seen when the artery was 
under a normal arterial pressure of 100 mmHg may be caused by the increased tension 
which it induces. This increased tension may lead to an increase in the frequency of the 
rhythmic activity to such an extent that the oscillations become fused together therefore 
giving a smooth maintained constriction.
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CHAPTER 4
ELECTRICAL FIELD STIMULATION OF 
THE RABBIT SMALL SAPHENOUS VEIN
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INTRODUCTION
Electrical field stimulation of the rabbit small saphenous vein
Electrical field stimulation is an in vitro technique which has been used over the 
years to give scientists more information about the degree of neural control present in 
the vasculature. It has been known for some time that the extrinsic neural control in 
most vessels is exerted predominantly via postganglionic adrenergic nerve fibres. This 
conclusion has resulted from a series of studies employing a range of vascular 
preparations from both the arterial and venous side of the circulation (for references see 
Bevan & Su, 1973).
The pattern, distribution and density of this adrenergic innervation has been 
examined in detail in the rabbit by Bevan et al. (1974b) using fluorescence 
histochemistry. Numerous isolated vessels of varying size, function and regional 
location were used, with each having their diameter and wall thickness measured. As a 
comparison to their histochemical studies Bevan et al. also exposed each vessel to 
periods of both exogenously applied noradrenaline and electrical field stimulation. In 
this way they could relate the maximum response to noradrenaline to the magnitude of 
the neurogenic contractile response induced by the field stimulation. By comparing the 
density of adrenergic innervation to the size of the contractile response they concluded 
that there was a direct relationship between the two. In other words the denser the 
adrenergic innervation present in a vessel, the greater the contractile response produced 
by the vessel for a given stimulus. This was a conclusion which had been reported two 
years previously by Gillespie & Rae (1972), though their conclusions went further. 
They suggested, in arteries, that the wall thickness to lumen ratio was also related to the 
size of the neurogenic response. However, Bevan et al. (1974b) disregarded this 
theory when they found there to be no direct relationship between density of adrenergic 
innervation and wall thickness to lumen ratios.
The distribution of this adrenergic innervation is also an important factor 
determining the magnitude of the neurogenic response. Vessels exhibiting a smaller 
neurogenic response were found to have their adrenergic nerves confined to a plexus 
localized on the adventitio-medial junction. Whereas vessels like the proximal 
saphenous artery and the small saphenous vein, which exhibit a large neurogenic 
response, possess adrenergic varicosities also within the tunica media (Bevan et al., 
1974a,b). The presence of this deeper innervation allows a more precise neurogenic 
excitatory control and one of greater magnitude than when the effector cells are 
activated by the release of transmitters from more remote sites. It seems logical that 
these more superficially located vessels, like the saphenous vein, should have the
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greatest range of neurogenic responses, since it is these same vessels which undergo 
the greatest amount of active vasoconstriction to cope with the various environments to 
which an animal is exposed.
Electrical field stimulation has initially involved preparations being cut either into 
rings or helical strips and being attached to a transducer for the recording of isometric 
tension. Silver/silver chloride, or preferably platinum, electrodes are placed near the 
vessel. The electrodes are connected to a stimulator which can deliver pulses of 
variable pulse width, frequency, duration and voltage. In practice the pulse width 
should be kept at or below two milliseconds to prevent direct constriction of the smooth 
muscle. The frequency is varied between 0.2 and 64 Hertz and the voltage is 
supermaximal (usually >20 volts). Duration of stimulation is often until a plateau has 
been reached, previous studies having shown (Brandao et al., 1985) that prolonged 
electrical stimulation could not exhaust stores of adrenergic transmitter. These four 
parameters are usually varied during an experiment to find the optimal conditions for 
inducing the maximum degree of vessel constriction.
Delivery of these pulses results in the release of noradrenaline from the adrenergic 
terminals which makes its way, by diffusion, across the synaptic cleft. This released 
noradrenaline then activates postjunctional a-adrenoceptors and causes the smooth 
muscle to constrict (via cGMP). Prejunctional a 2 -adrenoceptors are also present on the 
terminals and are involved in the re-uptake of this released noradrenaline located in the 
synaptic cleft. Using preparations such as rabbit pulmonary vein and aorta, which have 
a predominance of ai-adrenoceptors postjunctionally, has shown potentiation of 
stimulation-evoked responses after addition of 0C2 -antagonists. This potentiation has 
been attributed to the blockade of the prejunctional ot2 -adrenoceptors, resulting in an 
increased noradrenaline release. The absence of this potentiation in some tissues has 
implicated the existence of postjunctional (X2 -adrenoceptors in these vessels. One such 
vessel is the saphenous vein which has been used extensively to acquire further 
information on the importance of postjunctional (X2 -adrenoceptors in the neurogenic 
response.
The saphenous vein is a preparation known to contain both a i -  and 0C2 - 
adrenoceptors postjunctionally in the dog (Sullivan & Drew, 1980), in the human 
(Docherty & Hyland, 1985) and in the rabbit (Daly et al., 1988a,b). Results from the 
dog have suggested that nerve-mediated release of noradrenaline in this vessel 
preferentially activates postjunctional 0C2 -adrenoceptors to cause constriction. 
However, addition of prazosin (a  i-antagonist) or rauwolscine (a 2 -antagonist) will 
both significantly reduce this response (Flavahan et al., 1984). If both antagonists are 
given simultaneously then the response will be reduced even further, though a residual
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constriction will be maintained. Antagonists potencies in the human saphenous vein led 
to a similar conclusion as that stated for the dog saphenous vein, i.e. that the 0C2 - 
adrenoceptor is the dominant receptor involved in the nerve-evoked response (Docherty 
& Hyland, 1984). Work in the rabbit has been limited to the lateral saphenous vein 
(Daly et al., unpublished). They had found using various adrenoceptor antagonists that 
noradrenaline released from sympathetic nerve terminals acts mainly on a i -  
adrenoceptors. The (X2 -adrenoceptor component can contribute to the response but it 
requires facilitation from the a  1-adrenoceptors. For circulating noradrenaline the 
situation is the reverse, i.e. constriction is mainly via ot2 -adrenoceptors (Daly et al., 
1988).
Aims of the study
To study the response of the rabbit small saphenous vein to electrical field 
stimulation. A series of experiments on the postjunctional receptor populations present 
in this vessel had already been completed using various agonists, like noradrenaline, 
and the two selective antagonists prazosin and rauwolscine (Daly et al., 1988). This 
has shown the small saphenous vein to have a mixed postjunctional population of a i-  
and (X2 -adrenoceptors, with the (X2 -population being the dominant factor in the 
constriction process. By using image analysis and the same antagonists it would be 
possible to obtain a comparison between the exogenous application of noradrenaline 
and the noradrenaline released by neurally-evoked stimulation. This would show if the 
0C2 -adrenoceptor is the dominant one in the constriction produced by neurally-evoked 
stimulation as well as the stimulation produced by circulating noradrenaline. If this is 
so then it would contradict the theory that these a,2 -adrenoceptors are usually only 
located outside of the synaptic regions (Langer et al., 1980).
The effect of changes in the transmural pressure should also be analysed in the 
electrically stimulated rabbit small saphenous vein. This image analysis technique 
allows each vessel to be set up at an appropriate physiological pressure, which in the 
saphenous vein was set at 20 cmH2 0  (13 mmHg). By reducing this pressure the effect 
on the magnitude of the neurogenic response, produced by electrical field stimulation, 
would be studied.
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MATERIALS AND METHODS
Electrical field stimulation of the rabbit small saphenous vein
Electrical field stimulation was only studied in one vessel, the rabbit small 
saphenous vein, each experiment starting with a dose of 0.1 \iM UK-14304 to check 
the tissue was responding normally. Throughout these experiments the frame speed 
was increased to one per second to cope with the anticipated rapid constrictions 
produced by electrical stimulation. Initially stimulation involved using silver/silver 
chloride electrodes placed either side of the vessel, with the electrodes being connected 
to a stimulator. The stimulator was capable of delivering pulses of variable voltage, 
pulse width, frequency and duration to the blood vessel. In practice the pulse width 
was maintained constant at a value of 0.1 milliseconds. The other three variables were 
not kept constant, being used in various combinations to find what conditions were 
optimal for inducing the biggest constrictions in the vessel. Voltage values were 35-45 
volts, frequency values were 16-64 Hertz and duration values were 1-10 seconds. 
Stimulation occurred after the usual 20 photograph control period, with a further 3 
minutes recording stored on file to show the recovery of the preparation.
As an alternative to the silver/silver chloride electrodes a pair of platinum electrodes 
were also used to electrically stimulate the preparation. Initial experiments were similar 
to those performed using the silver/silver chloride electrodes, i.e. varying the voltage, 
frequency and duration of stimulation to find the best conditions for constricting the 
preparation. A series of experiments were then performed with each experimental day 
starting with a dose of 1 nM noradrenaline to check the functionality of the tissue. The 
stimulator was set at voltage = 2 0  volts, pulse width = 0 .1  milliseconds, frequency = 
20 Hertz and duration = 2 seconds throughout these experiments. This level of 
stimulation had been shown to constrict the vessel to a similar degree as a dose of 1 0  
nM noradrenaline.
A comparison was then possible to see if rauwolscine (10 nM) and/or prazosin (0.1 
jiM) was more or less effective at blocking the response produced by electrical 
stimulation than against a 10 nM dose of noradrenaline. The protocol consisted of a 20 
second control period followed by the electrical stimulation and then a 2  minute 
recovery period. The tissue was then exposed to either rauwolscine or prazosin for 30 
minutes and the protocol was repeated. Both antagonists were then given for a further 
30 minutes and the stimulation was repeated again.
As a further insight into electrical stimulation the effect of altering the transmural 
pressure on the response to stimulation had been studied. The normal transmural
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pressure of 20 C111H2O (13 mmHg) was reduced by 5, 10 and 15 cm respectively by 
lowering the height of the reservoir supplying the vessel. Values for voltage, pulse 
width, frequency and duration were the same as that denoted in the previous paragraph.
109
RESULTS
The responses to electrical field stimulation has been studied in only one isolated 
vessel, that being the rabbit small saphenous vein. Ljung et al. (1975), using cut-rings, 
has shown this preparation to have a large adrenergic innervation, therefore making it 
very responsive to the application of electrical stimulation. Current results have also 
shown this vessel to contain a mixed population of postjunctional a-adrenoceptors, 
something which has also been noted in the adjacent lateral saphenous vein (Daly et al., 
1988b). Results from Langer et al. (1980) and Daly et al. (unpublished) have 
suggested that postjunctional ot2 -adrenoceptors, however, do not play as big a part in 
the neurally-evoked response as ai-adrenoceptors do. In other words they have 
concluded that noradrenaline released by electrical stimulation acts mainly on a i-  
adrenoceptors. In this study the importance of each a-adrenoceptor subtype in the 
neurally-evoked response will be determined for the small saphenous vein. These 
results can be compared with the corresponding importance for circulating 
noradrenaline.
Initially electrical stimulation was conducted to the isolated vessel via a pair of 
silver/silver chloride electrodes placed either side of the preparation. A stimulator 
delivered pulses of varying voltage, frequency and duration all of which failed to 
constrict the vessel by more than 3-4%. This surprisingly small constriction was not 
sufficient to accurately measure a-adrenoceptor populations, since this study required 
the response to be further selectively reduced using a-adrenoceptor antagonists.
To overcome this apparent failure the composition of the electrodes were changed 
from silver to platinum which gave more consistent results. The start of the experiment 
began with a dose of 1 nM noradrenaline to check the functionality of the vessel. After 
this the parameters for pulse width, voltage, frequency and duration of stimulation were 
fixed at values which would produce a constriction approximately equal to that elicited 
by 10 nM noradrenaline. These values were 0.1 milliseconds, 20 volts, 20 Hertz and 2 
seconds respectively.
Figure 30 shows the response produced by electrical stimulation at these values, 
with a 2 0  second control period proceeding it and a 2  minute recovery period following 
the stimulation. On average the three segments shown have been constricted by 
14.1%. The average time to peak was calculated to be 15 seconds, after which the 
vessel showed a slow recovery back to the baseline. This constriction was blocked by 
the addition of rauwolscine (10 nM) and/or prazosin (100 nM). These selective 
antagonists were added intraluminally for 30 minutes prior to electrical stimulation to 
allow sufficient time for diffusion through the vessel wall.
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Figure 30
Trace shows the percentage changes in the width for three segments from the rabbit 
small saphenous vein. The vessel was exposed to a short period of electrical 
stimulation at the end of the control period and then allowed to recover for 2 minutes.
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Rauwolscine was the first antagonist to be tried against the neurally-induced 
response (Fig. 31). The 14.1% constriction was reduced to a 4.6% constriction which 
means rauwolscine has knocked out approximately 67% of the initial response. As 
well as reducing the degree of constriction rauwolscine has also slightly increased the 
time to peak to a value of 19 seconds (as opposed to 15 seconds in its absence). 
Addition of prazosin on top of rauwolscine caused a further decrease in the response to 
electrical stimulation (Fig. 32). The presence of the two antagonists together has 
reduced the constriction to 1.8%, which represents an 87% reduction in the initial 
response. Although the degree of constriction has been further reduced by the addition 
of prazosin along with rauwolscine the time to peak has not. This was measured at 14 
seconds which is a value close to the one found in the absence of either antagonist.
Repeating the electrical stimulation on a subsequent day produced a similar looking 
response, though the magnitude was slightly reduced at 9.0% and the time to peak was 
increased at 21 seconds (Fig. 33). On this day prazosin was the first antagonist to be 
added, causing the response to be reduced to 5.6% (Fig. 34). This represents a 38% 
decrease of the initial constriction which is not as great as the reduction seen with 
rauwolscine. Time to peak after addition of prazosin had been increased to a value of 
25 seconds. Both antagonists together caused the same degree of inhibition as that seen 
on the previous day (i.e. 87% of response knocked out).
Conclusions to be drawn from this data are that, firstly, rauwolscine is more 
effective than prazosin as an antagonist against the constriction produced by electrical 
stimulation in the small saphenous vein. Average results show rauwolscine is capable 
of blocking about 57% of the initial response, while prazosin can only knock out about 
34%. Secondly, the order of addition of the antagonists does not make any difference 
to the magnitude of this antagonism when both are added. Finally, isolating the 0C2 - 
adrenoceptor response, by addition of prazosin, tends to increase the time to peak, 
while isolating the ai-adrenoceptor response, by addition of rauwolscine, tends to 
decrease the time to peak.
All these field stimulation experiments have been conducted under a transmural 
pressure of 20 cmH2 0  (13 mmHg). The importance of this parameter was examined 
by stimulating the vessel under the same conditions as used previously, but with 
varying values for pressure. Apart from the normal value of 20 cmH2 0  the stimulation 
was also conducted at pressures of 15, 10 and 5 cmH2 0 . Under the normal pressure 
electrical stimulation was observed to cause an average constriction equal to 2 .2 %. 
Figures 35, 36 and 37 show this same preparation's response to electrical stimulation at 
the reduced pressures of 15, 10 and 5 cmH2 0  respectively. These pressures changes 
have increased the response from 2.2% at 20 cmH2 0  to 4.0% at 15 cmH2 0  to 6.0 at 10
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Figure 31
This trace was obtained from the same tissue as the result shown in Fig. 30 and 
again shows the percentage changes in the width for three segments from the rabbit 
small saphenous vein. The vessel was exposed to a short period of electrical 
stimulation this time in the presence of the (X2 -antagonist rauwolscine (10 nM). This 
occurred at the end of the control period and was followed by a 2  minute recovery 
period.
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Figure 32
This trace was obtained from the same tissue as the results shown in Figs. 30 & 31 
and again shows the percentage changes in the width for three segments from the rabbit 
small saphenous vein. The vessel was exposed to a short period of electrical 
stimulation this time in the presence of the (X2 -antagonist rauwolscine (10 nM) plus the 
ai-antagonist prazosin (100 nM). This occurred at the end of the control period and 
was followed by a 2  minute recovery period.
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Figure 33
This trace shows the percentage changes in the width for three segments from the 
rabbit small saphenous vein. The vessel was exposed to the same protocol seen in Fig. 
30, i.e. a short period of electrical stimulation at the end of the control period and then 
allowed to recover for 2 minutes.
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Figure 34
This trace was obtained from the same tissue as the result shown in Fig. 33 and 
shows the percentage changes in the width for three segments from the rabbit small 
saphenous vein. The vessel was exposed to a short period of electrical stimulation this 
time in the presence of the ai-antagonist prazosin (100 nM). This occurred at the end 
of the control period and was followed by a 2 minute recovery period.
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Figure 35
This trace is a repeat of the protocol shown in Figs. 30 & 33. This time the 
transmural pressure had been reduced from 20 to 15 cmH20 before the experiment 
began to see how this effected the constrictor response produced by the electrical 
stimulation.
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Figure 36
Repeat of Fig. 35 this time under a transmural pressure of 10 cmE^O.
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Figure 37
Repeat of Fig. 35 this time under a transmural pressure of 5 nmHoO
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C111H2O and finally to 10.2% at the lowest pressure of 5 cmH^O. So there has been a 
steady increase in the magnitude of the response as the pressure was decreased, the 
increase being fairly linear in nature (see Fig. 38). Results in this study did show some 
variation between different experimental days though in general as the pressure was 
reduced then the magnitude of the response would increase.
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Figure 38
Graph shows the relationship between the transmural pressure (x-axis) and the 
percentage change in width (y-axis) caused by electrical field stimulation in the rabbit 
small saphenous vein. Each point represents the average level of constriction obtained 
for the three segments at each pressure value.
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DISCUSSION
Electrical stimulation of the rabbit small saphenous vein
Electrical field stimulation was restricted to one vessel, the rabbit small saphenous 
vein. This was chosen as the vessel for investigation for two main reasons. Firstly, its 
postjunctional receptor populations had been studied extensively using image analysis 
therefore revealing the relative contributions of the a i-  and (X2 -adrenoceptors in the 
constriction process induced by exogenously applied noradrenaline. With the response 
of the vessel clearly documented with respect to the actions of exogenously applied 
agonists (noradrenaline) and antagonists (prazosin and rauwolscine) an interesting 
comparison could be made with the response produced by neurally-released 
noradrenaline. In particular the degree of antagonism produced by prazosin and 
rauwolscine could be compared for the two types of stimulation. The second reason 
for using the small saphenous vein was the fact that it is a blood vessel with a high 
density of adrenergic innervation (Bevan et al., 1974b), which was shown by the same 
authors to coincide with a large constrictor response to electrical stimulation.
Although the saphenous vein is a preparation which has been studied extensively in 
a number of different species including the dog (Rooke, et al., 1983), humans 
(Docherty & Hyland, 1985) and even the rabbit (Ljung, et al., 1975) its response to 
electrical stimulation has not been analysed using the technique of image analysis. 
Initially this involved using silver/silver chloride electrodes which only produced small 
constrictions irrespective of the magnitude of the stimulation. These sifver/silver 
chloride electrodes have in the past also been found to be unsatisfactory. This is due to 
the fact that they react with the Krebs to form a deposit on the surface of the electrodes, 
which prevents them from delivering the full force of the electrical stimulation pulse. 
This lack of response was overcome by using the far more stable platinum electrodes.
Even the platinum electrodes did not produce responses as large as had been 
expected. A pulse of a pre-determined magnitude was delivered throughout the 
experiments to mimic the constriction produced by the exogenous addition of 10 nM 
noradrenaline which is equal to about 40% of the maximum response. Although on 
certain days the pulse produced a constriction of similar size to 10 nM noradrenaline it 
was not seen consistently. This lack of response is one which has been stated 
previously by Levitt & Hieble (1986), though they used the lateral saphenous vein and 
expressed their results in a slightly different form. However, the basic conclusion from 
both sets of results is that the tone produced by electrical stimulation is both highly 
variable and sometimes of a very small magnitude. The fact that both methods involved
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a perfusion technique may be one clue to the much smaller responses seen as compared 
to other, more invasive in vitro techniques.
Another possible reason comes from Brandao et al. (1985) who found, using the 
dog saphenous vein, that there is a noradrenaline pool which is resistant to electrical 
stimulation. It may be that the rabbit small saphenous vein also has a component which 
is resistant to this type of stimulation. This seems unlikely since Ljung et al. (1975) 
using the same preparation has shown constrictions equal to as much as 75% of the 
maximum response produced by exogenously applied noradrenaline. These large 
constrictions were, however, obtained by continuously stimulating the vessel until it 
reached a plateau. The duration of the stimulus with image analysis was only 2 
seconds at a frequency of 20 Hz. Ljung et al. (1975) has also stated that using 
frequencies above 8 Hz is really taking the stimulus out of the range which would be 
encountered by the tissue in vivo, since the postganglionic sympathetic fibres do not 
normally discharge at rates greater than this value.
The response which was obtained was shown to be mediated predominantly via 0t2 - 
adrenoceptors, with rauwolscine (10 nM) being more effective as an antagonist than 
prazosin (0.1 pM). This result agrees closely with similar experiments performed on 
the human saphenous vein by Docherty & Hyland (1985) who used yohimbine instead 
of rauwolscine as the 0C2 -antagonist but also found it to be much more effective that 
prazosin. Levitt & Hieble (1986) have also stated that prazosin has little effect in the 
rabbit lateral saphenous vein, while Flavahan et al. (1984) using the dog saphenous 
vein came to the conclusion that nerve-released noradrenaline preferentially activates the 
postjunctional 0C2 -adrenoceptors in this vessel.
There is, however, some conflicting evidence which suggests that in the rabbit 
lateral saphenous vein at least electrical stimulation is antagonised more effectively by 
prazosin than by rauwolscine (Daly et al., unpublished). They have found that even 1 
pM rauwolscine was not as effective an antagonist as 0.1 pM prazosin. This 
apparently wide difference in results obtained by this method (cut-ring) as opposed to 
the image analysis method does seem strange. Both methods have reported this 
preparation to have a mixed postjunctional population of a \-  and 0C2 -adrenoceptors 
(Daly et al., 1988b), with both stating that the constrictor response produced by 
exogenously applied noradrenaline is mediated mainly by the (X2 -population. Why in 
the cut-ring method this should be reversed when the stimulus is electrical stimulation is 
not entirely clear, though it is suggested that the 0C2-adrenoceptor requires facilitation 
from the ai-adrenoceptor.
Results produced by image analysis clearly do not agree with this conclusion. The 
slight difference in the region of saphenous vein used may be one explanation though it
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seems unlikely that its properties would vary so profoundly over such a small distance. 
A more plausible explanation is that the less invasive image analysis technique is able to 
expose a population of a 2-adrenoceptors which the cut-ring technique cannot. This is 
the same conclusion which was reached in the study of exogenously applied agonists 
(Chapter 1). Before this conclusion can be stated with certainty, time controls must be 
completed to prove that any alterations seen in the response of the tissue are not due to 
the passage of time. One thing both methods do agree on is the inability to totally 
abolish the response by the addition of both prazosin and rauwolscine together. What 
is responsible for this residual response is not known.
Time to peak as well as the magnitude of the response to electrical stimulation was 
altered by prazosin and rauwolscine. The faster response produced when the a i-  
adrenoceptor population was isolated with rauwolscine was something which had been 
seen to a more limited degree when the vein was stimulated by the exogenous addition 
of agonists. A possible explanation behind this faster a i  response and slower 0C2  
response is a difference in the coupling process though this is only speculation. 
Factors such as the presence of a 2 -adrenoceptors prejunctionally may also be important 
in controlling the speed of response.
Since image analysis, with its constant transmural pressure, is very different from 
techniques such as cut-rings it was decided to investigate the influence of pressure on 
the response to electrical stimulation. Bevan et al. (1974b) stated that the importance of 
neurogenic vasoconstriction did depend to some degree on the transmural pressure 
present inside the intact animal. Oberg (1967) went further in saying that unless the 
venous pressure in vivo was at least 5-10 mmHg then neurogenic vasoconstriction was 
of no importance. Here using pressure values both above and below this range image 
analysis has shown a linear relationship between size of response and transmural 
pressure. Lowering the pressure enables the vessel to be more responsive to electrical 
stimulation (i.e. to constrict more). This is presumably by a simple reduction in the 
forces exerting an outward extension of the smooth muscle therefore shifting the vessel 
to a different part of the length-tension curve. Experimental variations in this 
relationship between transmural pressure and constrictor response were present but the 
general trend was always there.
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GENERAL DISCTTSSTOTV
GENERAL DISCUSSION
This investigation was not meant to be was a detailed examination of any one 
particular aspect of vascular function. Instead a number of different areas have .been 
studied, some in quite a bit of detail while others only very briefly. This has 
incorporated the use of 4 different preparations and many different drugs. Although 
this has restricted statistical analysis of the results for many of the experiments 
undertaken, it has allowed a broad range of experiments to be conducted to show in 
which of the areas examined image analysis has provided fundamental advantages over 
other in vitro techniques. It has also uncovered any disadvantages this technique 
possesses and allowed, where possible, the appropriate adjustments to eradicate these 
problems.
Advantages of the image analysis technique
A list of the advantages initially seen with this technique was included in the general 
introduction. However, some of these advantages must be discussed in further detail, 
together with more recently discovered benefits which have become obvious since then. 
It was stated in the introduction that image analysis was a more sensitive technique 
which gave more reproducible results. The magnitude of this increased sensitivity was 
examined by the use of agonists such as noradrenaline and calculated to be as much as 
3000-fold in relation to other in vitro techniques. An exposure of postjunctional ot2 - 
adrenoceptors is the reason given for this increase, with it being noted that image 
analysis is working well within the physiological concentration range. Increases in 
sensitivity were also seen when using substances like acetylcholine which exert their 
effect through the endothelium.
As far as reproducibility is concerned there are two points worth making. Firstly, 
successive additions of an agonist often produce very similar responses even when 
their addition is separated by many hours. The second point is that even employing a 
protocol which involves numerous different drugs which must be added over an 
extended time period the removal of these drugs will usually result in the dimensions of 
the preparation returning to values which are close to the initial, pre-drug values. All 
these results seem to point to the fact that image analysis is a technique which can 
mimic the conditions found in vivo to a better extent than any other in vitro technique. 
This main reason behind this is the lack of damage caused during the dissection 
process, enabling structures such as the fragile endothelium to remain more intact.
126
The advantages are not only on the setting up side, with further advantages seen in 
the recording side as well. Apart from the fact that parameters such as tension and 
pressure can be closely controlled the whole set-up can be kept in a stable state 
throughout the day’s experimentation. The recording device with image analysis is a 
computer which is able to measure continuously and accurately the dimensional 
changes occurring in the preparation. Any baseline shifts, which are seen in all in vitro 
techniques throughout the course of the day, represent real alterations in these 
dimensions when using this technique. This fact cannot be stated with equal 
confidence when using other methods which employ electronic devices such as 
isometric transducers and which are more prone to alter their responsiveness as time 
proceeds.
Image analysis is also more tolerant to any limitations which can be caused at the 
dissection, setting-up or recording stage. Although the tissue must be cleared of any 
excessive connective tissue surrounding the vessel the Magiscan will still be able to 
accurately record variations in the width when the external walls are not entirely clean. 
In fact a slightly fuzzy image is preferred since it allows the Magiscan to average values 
for light intensity over a greater area on screen and therefore locate the point of 
inflection more precisely (to a fraction of a pixel). This point corresponds to the region 
where light intensity is changing most rapidly and represents the edge of the vessel. An 
entirely sharp, straight edge would not be found as accurately since the area to be 
averaged would be less (value only found to nearest whole pixel).
As mentioned in the methods a dye has to placed on the preparation to split up the 
vessel into individual segments for analysis. On some of the days the dye was not 
applied very precisely causing it to spread longitudinally along the vessel. However, 
the software written for the Magiscan showed a great deal of tolerance to this difficulty, 
enabling the dimensions of the vessel to be found accurately even when the spread of 
the dye was quite extensive. Slight variations in the lighting conditions did not alter the 
measured values, as long as they were not too severe.
Disadvantages of the image analysis technique
There were some disadvantages as well as the advantages listed above. The most 
obvious one when using a perfused preparation is the problem of side-branches. In 
many previous perfusion experiments this problem has been solved by tying off these 
branches with thread. This was not possible with image analysis since the ties would 
have interfered with the measurements made by the Magiscan. This limited the use of 
vessels to ones which had branch-free segments and in this way the drug 
concentrations both intra- and extraluminally could be stated with confidence.
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Another difficulty was that some preparations when set up were prone to rotation 
when constricted with agonists. This problem causes difficulties in finding the edge of 
the vessel with sufficient accuracy and is compounded by the fact that the dye is placed 
on the preparation as a series of lines. If dots of dye were used instead of lines this 
problem would be of a lesser importance. This was not possible since the edge of the 
dot was sometimes mistaken for the edge of the preparation, therefore resulting in 
artificially low width values being obtained.
Additional points of discussion
Apart from the advantages and disadvantages of this method the data exposed a 
number of additional characteristics which must be discussed in more detail. The first 
of these is the presence of a “background noise” seen in the vast majority of traces 
which were produced. These slight variations in the dimensions of the vessel are 
present throughout, even when the tissue is apparently under completely stable 
conditions. The reasons behind these variations may be related to minor changes in the 
lighting conditions or lateral movement of the preparation within the organ-bath. They 
may also be related to a difficulty in finding the edges of the preparation accurately as 
described earlier. In reality the magnitude of these variations (usually <0.2%) are small 
enough to be ignored when studying the much larger responses produced by vasoactive 
stimuli in the vessels.
The second thing which was consistently seen from the results was a small and 
highly variable length change as compared to the corresponding width change. It is not 
entirely surprising that the length changes are smaller since in general blood vessels, 
especially arteries, exert their effects by altering their diameters to cause changes in the 
resistance to flow. This involves activation of the circular smooth muscle layer which 
is a much thicker and altogether more important layer than the adjacent longitudinal 
smooth muscle layer. Why the length changes should be so variable is not obvious but 
may be related to the way in which the vessel is set up.
Although the changes in width were much larger and more predictable than the 
corresponding length changes, large variations in the width response were seen along 
the length of a vessel. These variations were recorded from segments of vessels 
adjacent to one another and could on occasion be equivalent to more than a two-fold 
difference in magnitude of response. A number of possible reasons could explain this 
anomaly. The deviations could be caused by changes in either the type (Bumstock & 
Warland, personal communication) or the quantity of the receptors responsible for the 
induced responses. Damage to parts of the endothelium could also alter the 
responsiveness along the length via the influence of EDRF, as could variations in the
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density of the adrenergic innervation. Alternatively the explanation could be a lot 
simpler, being due to varying amounts of connective tissue on the vessel which might 
restrict the dimensional changes in some regions more than others.
Plans for image analysis in the future
Future plans for on-line video image analysis are already under way with a 
programme having been written to analyse blood vessels using the Macintosh which 
seems an ideal computer for this work. It is a more powerful machine with a greater 
memory capacity than the Magiscan. At present the programme has only been written 
to cope with single vessels of similar size as have been used previously. The use of the 
dye Janus green has been eradicated with the computer now doing the job of dividing 
the vessel into separate segments of equal size for analysis. With the recent 
development of even more powerful computers the next stage will be to move on to the 
analysis of networks of vessels, employing simultaneous measurements of many parts 
of the network. In this way the dimensions of many branches of sequentially smaller 
size can be measured. The only limit to this analysis will be the difficulty in dissecting 
out such small vessels.
Ultimately the aim, via the use of inert dyes, is to analyse the lumen as opposed to 
the external diameter and hence produce a better picture of what is occurring in the 
vascular system. This will firstly be done in vitro and if successful will then be tried in 
vivo. What is hoped to be achieved is a more comprehensive study of all the aspects of 
vascular function which were previously analysed using the Magiscan.
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APPENDIX 1
DRUG ABBREV SU PPLIER EFFECT
Acetylcholine Chloride ACh Sigma releases EDRF
Angiotensin II (acetate salt) AH Sigma vasoconstrictor
Bayer K 8644 Bayer K BayerLeverkessen
Ca2+ entry blocker
BHT-920 Dichloride BHT-920 BoehringerIngelhiem (X2-agonist
Cocaine Hydrochloride Cocaine Macarthys blocks neuronal uptake of NA
Na2 EDTA EDTA None prevents oxidative degradation of NA
Sodium Flubiprofen 
Dihydrate
Flubiprofen Boots cycloxygenase
inhibitor
Bovine Haemoglobin Type 1 Hb Sigma binds EDRF
(-)-Noradrenaline Bitartrate NA Sigma ai/oc2 -agonist
Phenylephrine Hydrochloride Phenylephrine Sigma a  i-agonist
Prazosin Hydrochloride Prazosin Pfizer ai-antagonist
Propranolol Hydrochloride Propranolol Sigma p-antagonist
Rauwolscine Hydrochloride Rauwolscine Roth (X2 -antagonist
Sodium Nitroprusside SNP Roche
stimulates smooth 
muscle soluble 
guanylate cyclase
UK-14304.18 UK-14304 Pfizer (X2-agonist
GLASGOW f  
UNIVERSITY r
143
